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PPH24-001
FASTER, SAFER AND MORE COST-
EFFECTIVE CARE FOR PATIENTS
WITH PANCREATIC CANCER AFTER
IMPLEMENTATION OF A
PREOPERATIVE PATHWAY
COORDINATED BY NURSE SPECIALIST
IgnaceDE Hingh, Jennifer Demelinne, Harm Rutten,
Simon Nienhuijs, Fanny Heesakkers and Misha Luyer
Catharina Hospital Eindhoven, Netherlands
Introduction: For patients with pancreatic cancer, sur-
gical treatment is the only chance of long term survival.
The multi-disciplinary pre-operative diagnosis and stag-
ing is complex and frequently results in biliary drainage
due to logistical constraints and increasing jaundice in
affected patients. Since publication of the DROP-trial,
biliary drainage has been proven to result in more
post-operative complications. The current study exam-
ines whether the establishment of a preoperatively
pathway coordinated by a nurse specialist resulted in
faster, safer and more cost-effective care.
Method: To study the effect, the medical charts of all
patients operated 18 months before and 18 months
after implementation of the pathway (June 2011) were
reviewed. Main outcome measure was the proportion
of patients without pre-operative biliary drainage. Sec-
ondary outcome measures were duration of referral to
surgery, duration of 1st outpatient visit to final treat-
ment and the number of preoperative outpatient visits
prior to treatment.
Results: A total of 146 patients were enrolled: 66
before and 80 after implementation of the care path-
way. Both groups were comparable with regard to
demographic characteristics. After implementation of
the pathway, there was a significant decrease in time of
referral to surgery (3.6 vs. 4.7 weeks) of the diagnostic
process (2.2 vs. 3.0 weeks) and the number of preopera-
tive outpatient visits (1.4 vs. 2.0 times). Most relevant
was the decrease in the number of patients in whom
biliary drainage was required: from 40% to18% after
implementation of the care pathway.
Conclusions: Implementation of a preoperative path-
way coordinated by a nurse specialist has resulted in
faster, safer and more cost-effective care for patients
with pancreatic cancer. The number of patients requir-
ing pre-operative biliary drainage decreased more than
half. Implementation of a pre-operative pathway is
highly recommended.
PPH24-002
LAPAROSCOPE TOTAL LEFT
LOBECTOMY WITH GLISSONIAN AND
ANTERIOR APPROACH FOR
RUPTURED HEPATOCELLULAR
CARCINOMA AFTER EMBOLIZATION
Yi-Ju Wu
Show Chwan Memorial Hospital, Taiwan
Introduction: We report a case of ruptured HCC after
resuscitation and transarterial embolization (TAE),
who underwent laparoscope left lobetcomy by control
of left side Glissonian pedicle and anterior approach
1 week later.
Method: Pneumoperitoneum was established at a pres-
sure of 12 mm Hg. The other 4 trocars are located
.The massive blood clot was encountered due to the
previous rupture of HCC. These were removed and irri-
gated by suction. The round ligament was transected
using laparoscopic coagulation shears (LCS; Ethicon
Endo Surgery Industries, Cincinnati, OH), and the fal-
ciform and coronary ligaments are then dissected to
expose the suprahepatic inferior vena cava (IVC). Cho-
lecystectomy was done by laparoscope method as
usual, followed by extrahepatic access to the left side of
Glissonian pedicle (containing branches of segments 2–
4). After fully encircle of left side of Glissonian pedicle
by silk, a laparoscopic vascular stapler was introduced
into the pedicle, resulting in ischemic delineation of left
liver. After the stapler was fired, liver parenchyma was
dissected and divided with harmonic scalpel combined
with vascular stapler. The left and middle hepatic veins
were transected with vascular stapler. Finally the speci-
men of left lobe was detached from coronary ligament
and pull out through the suprapubic incision. The
abdominal cavity was drained after bleeding check.
Operative time was 240 min, with blood loss estimated
at 250 mL excluding the blood clot content due to
tumor rupture, without need for transfusion.
Results: Postoperative recovery was uneventfully and
the patient was discharged on the fifth postoperative
day.
Conclusions: Staged laparoscopic liver resection with
Glissonian and anterior approach for ruptured HCC
after arterial embolization is a feasible and safe proce-
dure.
PPH24-004
ENDOSCOPIC DOUBLE METALLIC
BILIARY AND DUODENAL STENTING
FOR MUTIGNANI TYPE I AND II
LESIONS
Syed Mujahid Hassan, Syed Mudassir Laeeq, Nasir
Hassan Luck and Abdur Rehman Khan
Sindh Institute of Urology and Transplantation,
Pakistan
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Introduction: Periampullary tumors can cause biliary
and gastric outlet obstruction simultaneously. Endo-
scopic Double Metallic Biliary and Duodenal Stenting
(EDMBDS) is technically difficult however it is appar-
ently the least invasive and more efficient palliative
option compare to surgical bypass or other percutane-
ous radiological interventions. Here we are presenting
two proto-type cases consistent with Mutignani type I
and II in which our intervention improved the quality
of life of the patients.
Method: EDMBDS was performed in two consecutive
patients using conventional procedure techniques and
under general anesthesia. Pyloric dilatation was
required in one patient to negotiate the duodenoscope,
while duodenal dilation was required in other to reach
the ampulla.
Results: Case 1: This middle aged gentleman had
biopsy proven ampullary tumor consistent with Mutig-
nani type II causing both biliary and duodenal obstruc-
tion. After duodenal dilation biliary stent (10 X
60 mm) was deployed first, followed by duodenal stent
(22 x 90 mm). The expansion of Nitinol duodenal stent
was not satisfactory so another steel based stent was
deployed which showed satisfactory expansion. Post
procedure course was uneventful. Both Jaundice and
gastric outlet obstruction relieved gradually. He was
able to tolerate soft diet. Later he developed metastasis
and died after 2 months.
Case 2: This 35 year old lady was diagnosed as carci-
noma head of Pancreas with local extension consistent
with Mutignani type I. After pyloric dilatation double
stenting (10 x 80 mm in cbd, 22 x 60 mm in duode-
num) was performed easily. The patient’s jaundice
resolved and she soon started taking regular diet. She
is still alive 3 months post procedure with a relatively
good quality of life.
Conclusions: EDMBDS may be technically difficult but
safe and less invasive. It has potential to improve qual-
ity of life and decrease morbidity.
PPH24-005
APPLICATION OF VOLUMETRY ON 3D
CT FOR LIVING DONOR LIVER
TRANSPLANTATION
Hyung Hwan Moon, Jae-Won Joh, Suk-Koo Lee,
Choon Hyuck Kwon, Jin Yong Choi, Wantae Cho,
Seung Hwan Lee, Jong Man Kim and Sung Joo Kim
Samsung Medical Center, Sungkyunkwan University,
Korea
Introduction: The purpose of this study was to evaluate
3D CT volumetry in the assessment of living donor liv-
ers for transplant and to compare this technique with
manual volumetry.
Method: Liver CT scan of 16 consecutively prospec-
tively liver donors were obtained under a liver trans-
plant protocol. We compared Rt. liver volume on the
3D CT volumetry and Rt. liver volume calculated on
2D CT with actual Rt. liver volume after hepatectomy.
Results: Error was calculated by a formula which was
(measured volume – actual volume)/actual volume. The
average error of volumetry on 3D CT was smaller than
that on 2D CT (8.1% vs. 9.4%). Remnant left liver
volume on 3D CT was bigger than that on 2D CT,
average 12%.
Conclusions: Measured volumetry on 3D is more accu-
rate for measuring Rt. liver volume for donation. How-
ever, careful application of volumentry on 3D CT is
needed for possibility of overestimating remnant liver
volume.
PPH24-006
ROLE OF SURGERY IN THE
MANAGEMENT OF BILIARY
COMPLICATIONS AFTER LIVING
DONOR LIVER TRANSPLANTATION:
NATIONAL LIVER INSTITUTE
EXPERIENCE
Ahmed Sherif, Osama Hegazy, Amr Sadek and Tarek
Ibrahim
National Liver Institute, Menoufiya University, Egypt
Introduction: The purpose of this work was to study
the role of surgery in the management of biliary com-
plications after living donor liver transplant.
Method: A retrospective analysis that was done on
recipients who underwent living donor liver transplant
at the National Liver Institute, from April 2003 to
August 2012 (185 cases).
Results: Biliary complications occurred in 69 cases
(37.3%). Bile leak was in 39 cases (21.1%) and biliary
stricture was in 40 cases (21.6%). The first line treat-
ment of biliary leak was conservative management in
23.1% while pigtail was placed in 76.9% of the cases
with biliary leak. The condition resolved in 33.3%
while 15.5% died receiving no further management.
ERCP was done in 33.3% while surgical intervention
was done in 17.9% of the cases as a second line treat-
ment. The first line treatment of biliary stricture was
ERCP in 95% while no treatment in 5% of the cases
with biliary strictures. The number of ERCP sessions
ranged from 1–4 times with the mean of 1.5 times. The
condition resolved in 67.5% while 5% died receiving
no further management. Surgical intervention was done
in 27.5% of the cases as a second line treatment. Surgi-
cal intervention was done in 26% of cases that had bili-
ary complications. The mean timing of surgical
intervention was 13.33 months. The outcome was
recovery in 72.2% and mortality in 27.8% of the cases.
Conclusions: Endoscopic and radiological management
can’t be considered to be the standard of care for all
cases across the board; the management of each patient
and their biliary complication must be considered on
an individual basis. Thus, it shouldn’t be taken for
granted that surgical intervention is indicated when all
endoscopic and radiological management fail and surgi-
cal intervention as an early line of treatment should be
taken into account in the future management of biliary
complications.
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PPH24-007
IDENTIFICATION ASSISTANCE USING
THREE DIMENSIONAL PORTAL
BRANCH MAPPING IN PORTAL VEIN
EMBOLIZATION
Takeshi Takamoto, Takuya Hashimoto, Kazuto Inoue,
Daisuke Nagasima, Yusuke Mitsuka, Yoshikazu
Maruyama and Masatoshi Makuuchi
Japanese Red Cross Medical Center, Japan
Introduction: Portal vein embolization (PVE) is widely
used for the purpose of preventing liver insufficiency
after major hepatectomy. In technical point of view, it
is required that embolization starts from the second- or
third-order portal veins (PVs) to avoid coil dislocation
and thrombosis expansion to main PV. However, over-
lapping PVs on direct portography disturb to identify
each third-order PVs and prevent leading of the cathe-
ter straightly into the target branch. In our institution,
we prepare three dimensional portal branches map
(3D-PVmap) reconstructed preoperative computer
tomography (CT). This map is three-dimensionally
visualized by shading rendering technique. It is simu-
lated and output as the same angle obtained in direct
portography for reference. We will introduce the 3D-
PVmap and evaluate its usefulness by measuring the
angle of right second-order PVs.
Method: From April 2007 to April 2010, 105 patients
underwent PVE. The angle of the anterior (a°) and pos-
terior (b°) portal trunk from coronal plane was mea-
sured by CT images. When the branches observed from
an angle of c° with right anterior oblique (RAO), the
anterior and posterior trunk is observed as a+c° and b-c°
respectively. Logically, the closer to zero these angles
become, the longer the portal trunk can be seen. The
number of patients whose portal trunk angle becomes
less than 45°, which is defined as “better angle”.
Results: Ninty-nine patients (94%) had better angle of
anterior portal trunk on anteroposterior (AP) view.
Nineteen (18%) had better angle of posterior trunk on
AP. When the view angle is shifted to RAO 30°, totally
67 patients (64%) had better angle of posterior trunk.
Conclusions: In present study, one-third of the patients
failed to show better angle of posterior branch even
when practical angle of RAO view is taken. Therefore,
3D-PVmap can complement direct portography in
identifying not only third-order PVs but also second-
order PVs.
PPH24-008
CO-EXISTING TUBERCULOSIS LEADS
TO OVERESTIMATION OF NODAL
STATUS BY PET SCAN
Sudeep Shah, Devendra Desai and Sachin Almel
PD Hinduja Hospital, India
Introduction: Staging and monitoring of recurrence for
biliopancreatic cancer may be done using 18FDG- PET
scanning. Inflammatory conditions mimic malignant
deposits. Identification of this is crucial in appropriate
tumour staging. As co-existent tuberculosis is common
in developing countries, we evaluated the overstaging
of nodal status by PET scan.
Method: Retrospective review of patients undergoiong
18FDG PET scan for tumour staging or recurrence for
biliopancreatic malignancies between 2010 and 2012.
All tumours were biopsy proven. Nodes which were at
unusual locations or which failed to resolve with che-
motherapy were subjected to biopsy.
Results: Three patients were identified- one with locally
advanced cancer of the gallbladder had a positive right
supraclavicular lymph node, a patient with cancer gall-
bladder had extensive abdominal lymphadenopathy
that did not respond to chemotherapy inspite of near
resolution of gallbladder mass and a patient with
resected T2N1 cancer of head of pancreas developed
bilateral iliac lymph nodes which were PET avid
2 months after completion of 6 cycles of adjuvent che-
motherapy. In all cases the nodes were biopsied and
found to have tuberculosis. All received appropriate
treatment with good symptom response and the patient
with gall bladder cancer was subjected to radical chole-
cystectomy where it was confirmed that all the nodes
had tuberculosis and no evidence of malignancy.
Conclusions: Tuberculosis can mimic malignancy on
18FDG PET scan and can lead to false indication of i-
noperability or recurrence of disease. Due precaution
must be taken in interpretation of PET scans in
patients from developing countries where tuberculosis
is endemic.
PPH24-009
SEVERE COMPLICATIONS WITH
HEMOBILIA IN PATIENT ON ASPIRIN
REGIMEN AFTER EUS-FNA FOR
PANCREATIC HEAD CANCER
Ryoji Takada, Reiko Ashida, Hironari Sueyoshi,
Takuo Yamai, Nobuyasu Fukutake, Tatsuya Ioka,
Hiroyuki Uehara and Kazuhiro Katayama
Osaka Medical Center for Cancer and Cardiovascular
Diseases, Osaka, Japan
Introduction: EUS-FNA is a vital procedure in the
accurate diagnosis of pancreatic tumors and its safety
has recently been well-recognized all over the world.
Actually, many hospitals in Japan have been perform-
ing it since 2010. And now, anti-thrombotic therapy is
widely used for the prevention of heart attacks and
strokes. In the following paragraphs, we will explore a
case of hemobilia in a patient, after EUS-FNA.
Method: A case report.
Results: A 73-year-old man was introduced to our hos-
pital after endoscopic retrograde biliary drainage
(ERBD) with plastic stent for obstructive jaundice. He
was on an aspirin because of previous lacunar cerebral
infarction.
CT revealed a pancreatic head tumor. EUS-FNA was
performed from the duodenal bulb after halting aspirin
for 7 days. Three needle passes were performed without
any sign of acute bleeding such as fluid collection or
continuous intraluminal bleeding. The on-site cytologi-
cal specimen revealed adenocarcinoma.
Because his general state and laboratory tests after
EUS-FNA showed no abnormalities, aspirin was
restarted the next day. However, after 5 days of the
procedure, he suddenly complained of strong abdomi-
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nal pain and developed a high fever. A laboratory test
revealed elevated serum hepatobiliary enzymes suggest-
ing obstructive jaundice by stent occlusion. A duodeno-
scope showed that blood was blocking the ERBD
stent. A fully covered expanding metallic stent was
placed in the bile duct for hemostasis of hemobilia and
biliary drainage. He had septic shock with DIC due to
acute cholangitis for a few days but recovered by fol-
lowing conservative therapy.
Conclusions: We restarted an anti-thrombotic therapy
according to Japanese guideline, but we experienced
this case. We should continue to study the effects of
anti-thrombotic therapy on post EUS-FNA patients in
order to discover any correlation between the medica-
tion and the procedure.
PPH24-010
COST-EFFECTIVENESS OF
DIAGNOSTIC LAPAROSCOPY FOR
ASSESSING RESECTABILITY IN
PANCREATIC AND PERIAMPULLARY
CANCER
Stephen Morris1, Kurinchi Gurusamy2, Nishma Patel1
and Brian Davidson2
1University College London, United Kingdom;
2University College London and Royal Free Hospital,
United Kingdom
Introduction: Surgical resection is the only curative
treatment for pancreatic and periampullary cancer, but
a significant proportion of patients undergo unneces-
sary laparotomy because of understaging of the
tumours by computerised tomography (CT) scanning.
A recent Cochrane Review found that diagnostic lapa-
roscopy can decrease unnecessary laparotomy. We
compared the cost-effectiveness of diagnostic laparos-
copy versus direct laparotomy in patients with pancre-
atic and periampullary cancer who were resectable
based on CT scanning.
Method: Model based cost-utility analysis estimating
mean costs and quality-adjusted life years (QALYs) per
patient from the perspective of the UK National
Health Service over a 6 month time horizon. A decision
tree model was constructed and populated with proba-
bilities, outcomes and cost data from published sources.
One-way and probabilistic sensitivity analyses were
undertaken.
Results: Diagnostic laparoscopy did not increase costs
compared with direct laparotomy (mean cost per
patient £7470 vs. £7480); the cost of the diagnostic lap-
aroscopy (£995) was offset by avoiding the costs of
unnecessary laparotomy. Diagnostic laparoscopy pro-
duced more QALYs (mean QALYs per patient 0.346
vs. 0.337). Results were sensitive to key model parame-
ters for test accuracy. Diagnostic laparoscopy had a
60–65% probability of being cost-effective at a maxi-
mum willingness to pay for a QALY of £20 000 to £30
000.
Conclusions: Diagnostic laparoscopy in patients with
CT resectable pancreatic and periampullary cancer
appears to be cost-effective, producing a small improve-
ment in health outcomes at no extra cost.
PPH24-011
COST-EFFECTIVENESS OF
PREOPERATIVE BILIARY DRAINAGE
FOR OBSTRUCTIVE JAUNDICE IN
PANCREATIC AND PERIAMPULLARY
CANCER
Stephen Morris1, Kurinchi Gurusamy2, Nishma Patel1
and Brian Davidson2
1University College London, United Kingdom;
2University College London and Royal Free Hospital,
United Kingdom
Introduction: There is controversy as to whether preop-
erative biliary drainage (PBD) is beneficial to patients
with obstructive jaundice. A recent Cochrane Review
found that PBD in patients undergoing surgery for
obstructive jaundice is associated with similar mortality
but increased serious morbidity compared with no PBD.
The Cochrane Review concluded that PBD should not
be used routinely. We compared the cost-effectiveness of
PBD versus direct surgery for obstructive jaundice in
patients with pancreatic and periampullary cancer.
Method: Model based cost-utility analysis estimating
mean costs and quality-adjusted life years (QALYs) per
patient from the perspective of the UK National
Health Service over a 6 month time horizon. A decision
tree model was constructed and populated with proba-
bilities, outcomes and cost data from published sources.
One-way and probabilistic sensitivity analyses were
undertaken.
Results: PBD was more costly than direct surgery
(mean cost per patient £10 775 vs. £8221) and produced
fewer QALYs (mean QALYs per patient 0.337 vs.
0.343). PBD had a 10% probability of being cost-effec-
tive at a maximum willingness to pay for a QALY of
£20 000 to £30 000.
Conclusions: PBD for obstructive jaundice in patients
with pancreatic and periampullary cancer is not cost
effective. Not performing PBD would result in cost sav-
ings of approximately £2500 per patient.
PPH24-012
LAPAROSCOPIC APPROACH IS
SUITABLE FOR TREATMENT OF
PANCREATIC NEUROENDOCRINE
TUMOR
Takanori Morikawa, Takeshi Naitoh, Takeshi Aoki,
Hiroki Hayashi, Takaho Okada, Kei Nakagawa,
Hiroshi Yoshida, Fuyuhiko Motoi, Yu Katayose and
Michiaki Unno
Tohoku University, Japan
Introduction: Pancreatic neuroendocrine tumor (pNET)
is considered to be a good candidate for laparoscopic
surgery. However, there has been a few reports about
laparoscopic approach for pNET tumors derived from
pancreas and considered to be a good candidate for
laparoscopic surgery. However, there has been a few
reports about laparoscopic approach for pNET to date.
Therefore, we report laparoscopic surgical technique
for pNET and our results of this method.
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Method: Indication for laparoscopic approach is tumor
in diameter less than 2 cm without distal metastasis
and gastrinoma is excluded. Laparoscopic distal pan-
createctomy (LDP) is performed for the tumor which is
close to the main pancreatic duct (MPD) and located
at the pancreatic body or tail, and currently laparo-
scopic spleen preserving distal pancreatectomy
(LSPDP) has also been introduced, and is carried out
with the splenic vessels preservation in all the cases.
Laparoscopic enucleation (LEn) is performed using
electric cautery for the tumor which is far enough away
from the MPD.
Results: Between January 2000 and December 2012, 25
cases with pNET underwent laparoscopic pancreatic
surgery (LDP: 12 cases, LSPDP: 5, LEn: 8). Among
these three groups, tumor size in the LEn group was
significantly smaller compared with the LDP group,
and fasting period after operation was significantly
shorter in the LSPDP group than in the LEn. In com-
parison with open approach, sex ratio, age, and tumor
size were not significantly different, but all the patients
with simultaneous metastasis had undergone open sur-
gery. There was no significant difference in recurrence-
free survival rate between open and laparoscopic
approach.
Conclusions: Our criteria for laparoscopic surgery for
pNET are appropriate, and laparoscopic resection is
recommended to the tumor suitable for this criteria.
PPH24-013
MR IMAGING IN DIFFERENTIAL
DIAGNOSIS AND STAGING
OF EXTRAHEPATIC
CHOLANGIOCARCINOMA (SINGLE
CENTER EXPERIENCE)
Oleksandr Ganich1, Tatyana Golovko1, Andrii
Lukashenko2 and Igor Shchepotin2
1National Cancer Institute, Ukraine; 2National Cancer
Institute, Ukraine
Introduction: Cholangiocarcinoma is the most frequent
biliary malignancy. It is difficult to diagnose owing to
its anatomic location, growth patterns and lack of defi-
nite diagnostic criteria.
Method: The aim of our study was to measure sensitiv-
ity and specificity of magnetic resonance imaging
(MRI), multy detector computer tomography (MDCT),
ultra sound (US) in detection, differential diagnosis
and staging of extrahepatic cholangiokarcinoma (ECC).
MRI where performed for 27 patients, which was direc-
ted after US & MDCT with suspected diagnosis extra-
hepatic cholangiokarcinoma with obstructive jaundice,
for differential diagnosis and staging. For all patients
were performed MRI with dynamic bolus enhance-
ment.
Results: Of the 27 patients which were examined diag-
nosis of extrahepatic cholangiocarcinoma with MRI
was confirmed in 21 cases (78%). The remaining 6
cases were 1 liver abscesses, 1 holedahlitiaz, 4 tumors
of the pancreas. In the following control group
included 14 cases where conducted subsequent surgical
treatment. We have determined that MRI allowed to
deliver the correct extension stage of the process for
Bismuth-Corlette with a sensitivity of 95%, as opposed
to 65% of MDCT and ultrasound 60%. By identifying
lymph nodes, we have almost identical MRI and
MDCT data 85% and 80%, and 70% of the US. MRI
showed a sensitivity to the determination of the
involvement of the hepatic vessels 80% as opposed to
90% of the MDCT.
Conclusions: Imaging tools, mainly magnetic resonance
imaging and multi detector computer tomography,
allow full assessment of the extension of the tumor.
They are especially useful in establishing the correct
diagnosis, staging and determining of resectability.
PPH24-014
THE UTILITY OF 99MTC-LABELLED
GALACTOSYL-HUMAN SERUM
ALBUMIN LIVER SCINTIGRAPHY FOR
PREOPERATIVE ESTIMATION OF
REMNANT LIVER FUNCTION OF HCC
PATIENTS
Atsushi Miki, Yasunaru Sakuma, Hideki Sasanuma,
Yuji Kaneda, Yukihiro Sanada, Naohiro Sata and
Yoshikazu Yasuda
Jichi Medical University, Japan
Introduction: Hepatocellular carcinoma is often accom-
panied by chronic liver disease that is deteriorating
liver function. The aim of this study was to assess pre-
operative estimation of remnant liver function using
99mTc-labelled galactosyl-human serum albumin liver
scintigraphy and computed tomography.
Method: Thirty-nine patients with hepatectomy per-
formed in Jichi Medical University were studied. Liver
function was estimated by both liver 99mTc GSA
SPECT and computed tomography (CT). Preoperative
remnant liver function was defined by hepatic regional
99mTc GSA clearance using SPECT and CT fusion
image. Posthepatectomy liver failure (PHLF) was
defined following as the definition of International
Study Group of Liver Surgery.
Results: Ten patients (25.6%) of 30 patients developed
liver failure. Patients with remnant liver function less
than 140 mL/min developed liver failure after hepatec-
tomy. Regression analysis of remnant liver GSA clear-
ance correlated with postoperative total bilirubin
(R = 0.62, p < 0.01) and PT-INR (R = 0.53, p < 0.01).
Areas under the ROC curves for remnant liver GSA
clearance, remnant liver functional volume, and LHL15
for the estimation of PHLF were 0.98, 0.94, and 0.74
respectively.
Conclusions: Remnant liver GSA clearance is useful in
evaluating the risk of postoperative liver failure, which
is assistance in the appropriate decision of surgical indi-
cation.
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PPH24-015
EFFECTS OF IMMUNONUTRITION ON
INFLAMMATORY RESPONSES AND
RESOLVIN E1 IN PATIENTS
UNDERGOING MAJOR
HEPATOBILIARY RESECTION
Hidehiko Uno, Katsunori Furukawa, Daisuke Suzuki,
Hiroaki Shimizu, Masayuki Otsuka, Atsushi Kato,
Hideyuki Yoshitomi, Tsukasa Takayashiki, Satoshi
Kuboki and Masaru Miyazaki
Chiba University Graduate School of Medicine, Japan
Introduction: Although several studies have reported
the effects of immunonutrition on clinical outcome, the
detailed mechanisms of immunonutrition after surgery
are not yet clear. It has been recently reported that re-
solvin E1 (RvE1), which is one of the novel lipid media-
tors generated from eicosapentaenoic acid (EPA),
activates inflammation-resolution programs. This study
was designed to investigate the effect of preoperative
immunonutrition on surgical complications, and the
participation of RvE1 on inflammatory responses in
patients undergoing major hepatobiliary resection.
Method: Forty patients who underwent major hepatob-
iliary resection were divided into two groups. Twenty
patients received oral supplementation enriched with
EPA, arginine, and RNA for five days before surgery
(group IN). As the control group, twenty patients
received no artificial nutrition and were allowed to con-
sume regular food before surgery (group C).
Results: The rate and severity level of complications
(Clavien-Dindo classification) was significantly lower in
group IN than in group C. The length of hospital stay
was shorter in group IN than in group C. The plasma
level of RvE1 was significantly higher in group IN than
that in group C immediately after surgery. The plasma
level of IL-6 was significantly lower in group IN than
that in group C immediately after surgery and on post-
operative day 1. The serum level of EPA was signifi-
cantly higher in group IN than in group C during
perioperative periods. The preoperative level of serum
EPA was correlated with the plasma level of RvE1
immediately after surgery. The plasma level of RvE1
was inversely correlated with the plasma level of IL-6
immediately after surgery.
Conclusions: Preoperative immunonutrition reduced
inflammatory responses and protect against the aggra-
vation of surgical complications in patients undergoing
major hepatobiliary resection. RvE1 may play an
important role in these effects of immunonutrition.
PPH24-016
USEFULNESS OF MEASURING
FUNCTIONAL LIVER VOLUME BY
USING 99MTC-GALACTOSYL HUMAN
SERUM ALBUMIN SCINTIGRAPHY
SINGLE-PHOTON EMISSION
COMPUTED TOMOGRAPHY
Takafumi Kumamoto, Kuniya Tanaka, Kohei
Kasahara, Kazunori Nojiri, Ryutaro Mori, Koichii
Taniguchi, Ryusei Matsuyama, Kazuhisa Takeda,
Hirotoshi Akiyama and Itaru Endo
Yokohama City University Graduate School of
Medicine, Japan
Introduction: Preoperative assessment of hepatic func-
tion of future remnant liver is still a major issue in he-
patobiliary surgery. We investigated the usefulness of
measuring functional liver volume using 99mTc-galac-
tosyl human serum albumin (GSA) scintigraphy single-
photon emission computed tomography/computed
tomography (SPECT/CT) imaging.
Method: We performed a prospective analysis of 25
patients with colorectal liver metastases or hepatocellu-
lar carcinomas, underwent hepatic resection after portal
vein embolization (PVE), and evaluated their functional
liver volume perioperatively with GSA SPECT/CT.
The percentage of the non-tumorous remnant liver vol-
ume (%LV) and the percentage of functional remnant
liver volume (%FLV) were estimated. We have been
using the prediction score (PS) (Yamanaka et al. Ann
Surg. 1994; 219(4): 342-6) which was consists of%LV,
indocyanine green retention rate, and patient’s age for
predicting postoperative liver failure. We compared the
PS and modified PS (mPS) which adopted%FLV
instead of%LV for prediction of postoperative liver
failure using Area under receiver operatorating charac-
teristic curve (AUC).
Results: The%LV increased significantly, from 39.6 to
53.5%, and the increment was 13.9% (p < 0.01). The%
FLV was also increased significantly, from 43.1 to
62.4%, and the increment was 19.3% (p < 0.01). The
increment was 5.4% greater for the%FLV compared to
that of the%LV (p = 0.01). All patients were received
subsequent operation following PVE. Postoperative
liver failure of grade B and C (ISLGS definition)
occurred in 2 cases. AUC of PS and mPS were 0.674
and 0.913, respectively.
Conclusions: Increment of%FLV was greater than that
of%LV between before and after PVE. Accuracy of the
prediction of the postoperative liver failure may be
improved by FLV using GSA SPECT/CT.
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PPH24-017
NONINVASIVE DIAGNOSIS OF
COMPENSATED CIRRHOSIS BY
ANALYSIS OF TIME INTENSITY
CURVE PORTAL VEIN SLOPE
GRADIENT USING CONTRAST-
ENHANCED ULTRASONOGRAPHY
Yuichi Goto, Koji Okuda, Hisamune Sakai, Gen
Akasu, Toshihiro Sato, Kenjiro Fukuyo, Yusuke
Hirakawa, Hisafumi Kinoshita and Hiroyuki Tanaka
Kurume University, Japan
Introduction: We measured vascular time intensity
curves (TIC) as slope gradients (SG) of intrahepatic
vessels via contrast-enhanced ultrasonography (CEUS).
The aims were to assess the diagnostic accuracy of the
SG of each hepatic vessel, particularly of the portal
vein (PV), for cirrhosis, and to compare this method
with conventional modalities.
Method: Fifty-one preoperative patients underwent
CEUS, and TIC was plotted. The SG of the hepatic
artery (HA), PV and hepatic vein (HV) were obtained
from the linear functions between the slope of the arri-
val time of the contrast agent and the peak enhance-
ment time of each vessel. Transit times and biochemical
markers were also measured. Patients were divided into
three groups according to Metavir score: F0/1 group
(n = 14), F2/3 group (n = 21) and F4 group (n = 16).
Results: The PVSG was decreased significantly in the
F4 group (F0/1: 29.1  2.27, F2/3: 23.1  1.86, F4:
14.7  2.13). The PVSG showed high accuracy in diag-
nosing cirrhosis and was correlated with ICG-R15 and
hyaluronic acid (Spearman rank correlation;
q = 0.5691, p < 0.001 and q = 0.4652,
p = 0.0006).
Conclusions: The PVSG has the potential to be a diag-
nostic tool to identify well-compensated cirrhosis.
PPH24-018
THE GOOD IDEA FOR ADDITIONAL
INDICATION FOR SAFETY
LAPAROSCOPIC LIVER RESECTION
Nobuhiko Taniai, Hiroshi Yoshida, Junji Ueda,
Hideyuki Takada and Eiigi Uchida
Nippon Medical School, Japan
Introduction: Laparoscopic liver resection has been
reported as a safe and effective approach to the man-
agement of liver cancer. The aim of this study was to
analyze the operation outcome of laparoscopic liver
resection versus open liver resection.
Method: Between 1999 and 2012, 75 patients under-
went laparoscopic liver resection. Fifty eight patients
underwent pure laparoscopic liver resection, 3 patients
underwent hand assisted liver resection and 14 patients
underwent hybrid liver resection. Forty five patients
diagnosed of hepato-cellular carcinoma, 18 patients
metastatic liver tumor form colorectal cancer and 12
patients others. Patients received open liver resection
(n = 480) were included for comparison. Immediate
operation outcomes were compared between two
groups.
Results: With the laparoscopic group compared with
the open resection group, operation time was 310 min-
utes versus 320 minutes, blood loss was 392 mL versus
1075 mL, hospital stay after operation was 10 days ver-
sus 14 days. There were significant differences in blood
loss and hospital stay between two groups. Postopera-
tive complication was 10 (13.3%) versus 74 (15.4%).
Conclusions: Laparoscopic liver resection is associated
with less blood loss, shorter hospital stay.
PPH25-001
USE OF RETRIEVAL-BALLOON-
ASSISTED ENTEROGRAPHY FOR
Yingbin Liu, Wenguang Wu, Xuefeng Wang, Jun Gu,
Wenjie Zhang, Mingning Zhao and Ming Zhuang
Xinhua Hospital, School of Medicine, Shanghai Jiaotong
University, China
Introduction: Endoscopic retrograde cholangiopancrea-
tography (ERCP) is efficacious in patients with a Bill-
roth II gastroenterostomy, but the success rate
decreases in patients who also have a Braun anastomo-
sis. In the present retrospective study, we aimed to
describe the use of retrieval-balloon-assisted enterogra-
phy for endoscope insertion in challenging patients
with a Billroth II gastroenterostomy and Braun anasto-
mosis.
Method: In total, 109 and 20 patients who received
BillrothII gastroenterostomy, and Billroth II gastroent-
erostomy and Braun anastomosis, respectively, between
January 2009 and May 2013 were included in our
study.
Results: The overall success rate of enterography was
85% for the patients who had a Billroth II gastroenter-
ostomy and Braun anastomosis, and the therapeutic
success rate was 80%. Afferent loop perforation
occurred in 1 patient, which was detected during the
procedure. None of the patients had hemorrhage. For
simple Billroth II gastroenterostomy, ERCP was unsuc-
cessful because of failure in accessing the papilla in 15
patients (6 due to tumor infiltration and 9 due to a
long afferent loop) and failure in cannulation in 4
patients. The overall enterography success rate was
86.2%, and the therapeutic success rate was 82.6%.
Hemorrhage developed in 1 patient 2 hours after
ERCP.
Conclusions: We recommend that the duodenoscope
should be extended along the greater curvature of the
stomach, and then advanced through the ”efferent loop
entrance” at the site of the gastrojejunal anastomosis,
along the efferent loop, and through the ”middle
entrance” at the site of the Braun anastomosis to reach
the papilla of Vater. We believe that this is the optimal
enterography route for ERCP in patients who have
Billroth II gastroenterostomy and Braun anastomosis.
Retrieval-balloon-assisted enterography might improve
the enterography and therapeutic success rate in such
patients.
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PPH25-002
HEPATO-BILIARY PANCREATIC
TUBERCULOSIS
Chetan Kantharia, Sharvari Pujari, Ramkrishna
Prabhu, Avinash Supe and Ravindra Bapat
Seth GS Medical College & KEM Hopsital, Mumbai,
India
Introduction: Isolated hepatobiliary and pancreatic
tuberculosis (TB) is rare and preoperative diagnosis is
difficult. We report our experience of this rare site of
tuberculosis.
Method: Records of patients with proven histological
diagnosis of hepatobiliary and pancreatic tuberculosis
were reviewed retrospectively. The demographic fea-
tures, sign and symptoms, imaging, cytology/histopa-
thology, procedures performed, outcome and follow up
data were obtained. The diagnosis of tuberculosis was
based on granuloma with caseation necrosis on histo-
pathology or presence of acid fast bacilli.
Results: Heaptic Tuberculosis: 44 year old patient, pre-
sented with jaundice and ascites. A clinical diagnosis of
autoimmune hepatitis was considered. Her AMA and
ANCA test for autoimmune hepatitis were negative.
Liver Biopsy performed revealed presence of granu-
loma with caseation. She was started on 4 drugs AKT
for six months. At the end of three months her jaun-
dice subsided, with subjective improvement in increased
weight and appetite.
Biliary Tuberculosis: 16 year old presented with cholan-
gitis. Her imaging showed dilated CBD hence diagnosis
of Choledochal cyst was made. She was subjected to
surgery, when Hepatico-dochojejunostomy was done.
Histopathology of excised CBD revealed granuloma
with presence of caseation. Liver Biopsy done post
operatively was normal. Patient was started on 4 drug
AKT for six months, and patient is doing well.
Pancreatic Tuberculosis: 50 year patient presented with
a palpable lump in the supraumbilical region. Imaging
showed the lump in relation to the body of pancreas.
Patient was subjected to exploratory laparotomy with
excision of the lump. The lump contained pus, which
was positive for AFB culture. Patient was started on 4
drug AKT, and patient is doing well.
Conclusions: Tuberculosis should be considered as a
differential diagnosis, particularly in young patients
with atypical signs and symptoms coming from areas
where tuberculosis is endemic and preoperative tissue
and/or cytological diagnosis should be attempted
before labeling them as hepatobiliary and pancreatic
tuberculosis.
PPH25-003
EUS-GUIDED CORE BIOPSY
IMPROVES DIAGNOSTIC ACCURACY
IN THE EVALUATION OF
GASTROINTESTINAL STROMAL
TUMORS
Ali Ahmed, Michael Bass and Frank Gress
SUNY Downstate Medical Center, USA
Introduction: Gastrointestinal stromal tumors (GIST)
are stratified by mitotic index and diagnosed by immu-
nohistochemical staining. Endoscopic ultrasound (EUS)
permits the physician to precisely identify the submuco-
sal lesion and provide tissue for pathology.
EUS-guided fine needle aspiration (FNA) provides a
diagnostic accuracy of 60 to 90% with a false positive
rate of 5% to 7%. GISTs are diagnosed by immunohis-
tochemical staining of cellular elements that are not
always obtained by FNA. A novel EUS histology nee-
dle (FNB) was developed to obtain core specimens.
This study represents a secondary analysis comparing
the GIST diagnostic accuracy of EUS guided FNA and
FNB on samples procured from the same patient.
Method: Eight GIST lesions were identified in our lar-
ger prospectively compiled database of 75 patients
referred for EUS evaluation of upper GI lesions. Cook
and Boston Scientific FNA (22 g or 25 g and Echotip
ProCore Cook Medical FNB needle (19 g, 22 g) were
used by experienced endosonographers. Tissue was
obtained using both the FNA and FNB needle on the
same lesion without on-site cytopathology. The sample
acquisition technique, needle gauge and number of
passes were determined by the echoendosonographer.
Results: The patients had an average age of 73 years,
88% female 88%, 75% black without any complica-
tions. The average lesion size was 2.6 cm located in the
gastric fundus and body. The average number of needle
passes was greater for the FNA (4 vs. 2). Sample ade-
quacy was greater for the FNB needle (88% vs. 75%)
as was the diagnostic yield (86% vs. 71%). Sensitivity
values were comparable (FNA 83% and FNB 86%).
Conclusions: GIST lesions are often better diagnosed
using immunohistochemical staining. The novel FNB
needle provides the ability to extrude cellular elements
necessary to assist in this diagnosis. This study demon-
strates increased sample adequacy and diagnostic yield
for GIST tumors with the FNB needle.
PPH25-004
LAPAROSCOPIC SPLENECTOMY
FOLLOWING EMBOLIZATION FOR
BLUNT SPLENIC RUPTURE
Tetsuya Maeda, Yuichiro Otsuka, Masaru Tsuchiya,
Yoshihisa Kubota, Jun Ishii, Toshio Katagiri, Akira
Tamura and Hironori Kaneko
Toho University School of Medicine, Japan
Introduction: In trauma surgery, laparoscopy has had
only limited established applications, but improved
equipment and advanced surgical skill have created
greater opportunities for surgeons to apply minimally
invasive techniques to the surgical management of the
injured patient. We report a case of laparoscopic sple-
nectomy following embolization for blunt splenic rup-
ture in a patient, who could not be treated
conservatively.
Method: A 45-year-old man was transported to our
hospital after abdominal trauma that was injured by a
fall. CT scan revealed a complex type of splenic rupture
(Grade IV) and intra-abdominal bleeding. Central sple-
nic artery embolization was performed due to progress
anemia. However, Laparoscopic splenectomy following
embolization might be necessary in this case because of
the potential risk to repeat bleeding and develop splenic
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infarction with abscess formation. The patient was in
the right lateral position and laparoscopic splenectomy
was carried out with a laparoscopic coagulating shears
and a 60-mm endostapler.
Results: The surgical time was 194 minutes and opera-
tive blood loss was 400 mL. The postoperative course
was uneventful and the patient was discharged 11 days
after operation without any complications.
Conclusions: We believe that laparoscopic management
for blunt splenic rupture is one of the therapeutic strat-
egies available, and embolization may serve as a bridge
to operative therapy and make laparoscopy a safe.
PPH25-005
ENDOSCOPIC NASO-GALLBLADDER
DRAINAGE FOR THE TREATMENT OF
ACUTE CHOLECYSTITIS: TECHNICAL
AND CLINICAL RESULTS
Takumi Yamabuki1, Masanori Ohara1, Kunishige
Okamura1, Hiromitsu Domen1, Ryou Takahashi1,
Kazuteru Komuro1, Nozomu Iwashiro1, Toshiyasu
Iwao2 and Koji Yoshida3
1National Hospital Organization Hakodate Hospital,
Japan; 2Aizu Chuou Hospital, Japan; 3Kawasaki
Medical School, Japan
Introduction: Percutaneous transhepatic gallbladder
drainage (PTGBD) and percutaneous transhepatic gall-
bladder aspiration (PTGBA) were performed in
patients with acute cholecystitis. However, percutane-
ous drainage techniques were prohibited for patients
receiving anticoagulant or antiplatelet drugs, those with
bleeding tendency, and those with suspected gallbladder
complications. We retrospectively studied the technical
and clinical results of endoscopic naso-gallbladder
drainage (ENGBD) for acute cholecystitis.
Method: A total of 55 consecutive patients with acute
cholecystitis who received ENGBD from 2009 to 2013
were enrolled in the present study. The median age of
the patients was 76 years (range 53–96 years). The fre-
quency of success, tube placement period and complica-
tions of ENGBD for acute cholecystitis were measured.
Results: Technical success was achieved in 48 of 55
patients (success rate 87.3%). Clinical success was
achieved in 42 of 48 patients (success rate 87.5%). Cho-
lecystectomy was performed in 49 patients; the other
six patients were treated by only ENGBD because of
their advanced age or complications. The median tube
placement period was 8 days (range 2–20 days). The
complications were injury to the cystic duct in four
(7.3%) patients and acute pancreatitis in two (3.6%)
patient. Six (10.9%) patients accidentally removed the
ENGBD tube.
Conclusions: ENGBD seems feasible and effective in
treating acute cholecystitis. Further advancement of the
relevant skills is required for a higher technical success
rate.
PPH25-006
EXPERIMENTAL STUDY OF LASER
SPECKLE CONTRAST IMAGING IN
MONITORING LIVER
MICROCIRCULATION OF RATS AFTER
ISCHEMIA AND REPERFUSION
Chonghui Li, Hongdong Wang, Xinlan Ge, Ke Pan,
Jia Bai, AiQun Zhang and Jiahong Dong
Chinese PLA General Hospital, China
Introduction: The aim of the present study was to eval-
uate the use of laser speckle contrast imaging (LSCI) in
assessing liver microcirculation blood flux (LMBF)
before and after liver blood inflow clamping in rats.
Method: Male Wistar rats were assigned into sham
operation group (n = 5) and liver blood inflow clamp-
ing group (n = 8). The blood inflow to the left, median
and right liver lobes was clamped except the caudal
lobe which was kept as a bypass of the splanchnic
blood. LMBF was measured with LSCI before and
after the blood inflow clamping and reperfusion. Histo-
pathological analysis on the liver tissue was also per-
formed.
Results: The baseline LMBF of sham operation group
and clamping group were 882.11  103.78 and
855.61  117.58 LSPU respectively (p > 0.05). While
keeping the normal LMBF level in the sham operation
group, the LMBF of clamping group decreased to
464.97  92.20 LSPU (p < 0.05) after clamping the
liver blood inflow and remained at the same level after
2 h of clamping. After reperfusion of liver blood the
LMBF further decreased to 336.46  29.33 LSPU
(p < 0.05). When comparing the LMBF of the left, left
median and right median liver lobes of rats in clamping
group, only the left lobe’s LMBF was significantly
lower than that of the left median and right median
lobes after liver blood inflow clamping. Histopathologi-
cal examination revealed severe hepatic sinus conges-
tion, nuclei pyknosis and necrosis of hepatocytes in the
rat liver of clamping group after reperfusion.
Conclusions: LSCI was able to assess the changes of
LMBF induced by liver blood inflow clamping and rep-
erfusion, and reflect the ischemia reperfusion induced
liver microcirculation dysfunction. These results sug-
gested the possible application of LSCI not only in
liver microcirculation study but also in liver surgery.
PPH25-007
COST EFFECTIVENESS OF A
PROSPECTIVE STUDY REDUCING
FRESH FROZEN PLASMA IN LIVER
RESECTION
Shintaro Yamazaki, Tadatoshi Takayama, Tokio
Higaki and Masamichi Moriguchi
Nihon University School of Medicine, Japan
Introduction: The fresh frozen plasma (FFP) has been
transfused without adequate supporting evidence in
liver resection It leads to FFP unnecessary usage and
arises medical costs.
Method: Prospective study was performed on a phase I
dose-escalation, “3 + 3” cohort expansion design, mod-
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ified for FFP transfusion. All eligible patients had
Child-Pugh A liver function and an intraoperative
blood loss of less than 1000 mL. A serum albumin
level of 3.0 g/dL (step 1) as the starting limit for non-
transfusion and reduced the level in 0.2-g/dL steps.
Advancement to the next step was permitted when the
albumin level equaled the target value for the previous
step in three patients. The study continued until high-
grade postoperative complications occurred without
transfusion. If one of three patients had Clavien–Dindo
grade II or higher complications, three more patients
(“3 + 3” cohort) were added to the same step.
Results: Of the 213 consecutive patients with liver can-
cer enrolled, 172 (81%) fulfilled the inclusion criteria.
Step progression proceeded until step 5 (albumin,
2.2 g/dL) without high-grade complications, but step 2
(2.8 g/dL) required 63 patients to complete because one
patient had grade II complications (massive ascites).
Step progression was broken off at step 5 in the 172nd
patient because the POD2 albumin value did not fall
below the step 4 level (2.4 g/dL), defined as the goal
limit. The FFP transfusion rate was significantly
reduced from 48.6% in a previous series involving 222
patients to 0.6% (1/172 patients) in present study
(p = 0.001). The postoperative hospital stay in the pres-
ent study was significantly shorter than that in our pre-
vious series (13 vs. 16 days, p = 0.012) Total medical
costs were significantly reduced from median $21,061
USD [range 10,032–59,410] to $17,267 USD [11,823–
35,785] (p = 0.001).
Conclusions: Significant cost reduction was demon-
strated by prospective study in liver resection.
PPH25-008
PERCUTANEOUS TRANSHEPATIC
BIOPSY BY CHOLEDOCHOSCOPE IN
INTRAHEPATIC BILIARY TUMORS
Dongdo You1, Yong Sung Won1, Kee Hwan Kim2, Il
Young Park3 and Dong Gu Kim4
1Catholic University of Korea, St. Vincent’s Hospital,
Korea; 2Catholic University of Korea, Uijeongbu St.
Mary’s Hospital, Korea; 3Catholic University of Korea
Bucheon St. Mary’s Hospital, Korea; 4Catholic
University of Korea, Seoul St. Mary’s Hospital, Korea
Introduction: Intraductal papillary mucin-producing
neoplasm (IPMN) of the bile duct is a rare disease. The
precise diagnosis of biliary IPMN is not easy, especially
in intrahepatically located, by conventional endoscopic
retrograde cholangiopancreatography.
Method: A female-63 year old patient admitted to our
hospital complaining of right upper quadrant abdomi-
nal pain and fever. Abdominal computed tomography
(CT) scan showed both common bile duct and both
intrahepatic bile duct dilatation and endoscopic retro-
grade cholangiopancreatography showed a mucin like
soft mass projection after endoscopic sphincterotomy
yet biopsy did not reveal malignancy. Further evalua-
tion with magnetic resonance imaging (MRI) suggested
biliary IPMN or distal CBD cancer involving the right
hepatic duct. Percutaneous transhepatic biliary drain-
age (PTBD) catheter was inserted and choledochoscop-
ic biopsy was done revealing adenocarcinoma in the
peripheral right hepatic and common hepatic duct.
Results: A 52 year old man admitted to our hospital
due to intrahepatic duct dilatation on annual abdomi-
nal sonographic check-up. Liver CT scans revealed dis-
tal CBD narrowing near the ampulla and there were
longitudinal filling defects on both IHD and CHD on
ERCP, after EST pus like discharge was found. Biliary
parasitosis was suspected due to his history of ingestion
of raw fish liver and praziquantel trial was started.
After a follow loss of 20 months the patient was read-
mitted due to jaundice. Liver CT and ERCP showed
mass like findings at the common hepatic duct with
both intrahepatic duct dilatation. MRI findings sug-
gested biliary IPMN or atypical cholnagiocarcinoma.
Choledochoscopic biopsy after PTBD was done reveal-
ing intraductal tumor in the peripheral right hepatic
duct.
Conclusions: Before operation, the pathology and the
extent of the tumor were confirmed and surgical strat-
egy was easy to set up to right hemihepatectomy with
caudate lobectomy. Both patients were discharged with
no postoperative major complication.
PPH25-009
LAPAROSCOPIC SURGICAL BOX
MODEL TRAINING FOR SURGICAL
TRAINEES WITH NO PRIOR
LAPAROSCOPIC EXPERIENCE
Myura Nagendran1, Clare Toon2, Brian Davidson1 and
Kurinchi Gurusamy1
1University College London and Royal Free Hospital,
United Kingdom; 2West Sussex County Council, United
Kingdom
Introduction: The role of box training in surgical train-
ees with no prior laparoscopic experience is not fully
understood.
Method: A systematic review of literature was per-
formed by searching the Cochrane Library, MED-
LINE, EMBASE and Science Citation Index Expanded
for randomized controlled trials reported until May
2013. Two authors independently identified trials and
collected data. Standardized mean difference (SMD)
with 95% confidence intervals (CI) was calculated
based on an intention-to-treat basis using RevMan
software.
Results: Box-model training versus no supplementary
training: Sixteen trials (464 participants) provided data
for the analysis. The time taken for task completion
was significantly shorter (SMD 0.48 s; 95% CI 0.74
s to 0.22 s), the error score significantly lower (SMD
0.69; 95% CI 1.21 to 0.17), accuracy score signifi-
cantly higher (SMD 0.67; 95% CI 0.18 to 1.17), and
the composite performance score significantly better
(SMD 0.65; 95% CI 0.42 to 0.88) in the box-trainer
group than the control group. Different methods of
box training: Overall, 14 trials (382 participants) pro-
vided data for quantitative comparison of different
methods of box training. None of the methods of train-
ing were consistently superior to other methods of
training.
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Conclusions: Laparoscopic box-model training appears
to improve technical skills compared to standard surgi-
cal training (no training in this population) in trainees
with no previous laparoscopic experience. The impact
of this decreased time on patients and healthcare fund-
ers in terms of improved outcomes or decreased costs is
not known. There appears to be no significant differ-
ences in the improvement of technical skills between
different methods of box model training. Further well
designed trials of low risk of bias and random errors
are necessary. Such trials should assess the impact of
box-model training on clinical outcomes when the trai-
nee becomes competent to operate on patients.
PPH25-010
LAPAROSCOPIC SURGICAL BOX
MODEL TRAINING FOR SURGICAL
TRAINEES WITH LIMITED PRIOR
LAPAROSCOPIC EXPERIENCE
Kurinchi Gurusamy1, Myura Nagendran1, Clare Toon2
and Brian Davidson1
1University College London and Royal Free Hospital,
United Kingdom; 2West Sussex County Council, United
Kingdom
Introduction: The role of box training in addition to
standard apprenticeship model training in not fully
understood.
Method: A systematic review of literature was per-
formed by searching the Cochrane Library, MED-
LINE, EMBASE and Science Citation Index Expanded
for randomised controlled trials reported until May
2013. Two authors independently identified trials and
collected data. Risk ratio (RR), mean difference (MD),
or standardised mean difference (SMD) with 95% con-
fidence intervals (CI) were calculated on an intention-
to-treat basis using RevMan software.
Results: Seven trials (249 surgical trainees) comparing
supplementary box model training and standard train-
ing met the inclusion criteria. Only one trial (50 train-
ees) was at low risk of bias. The final assessments were
made on a single operative procedure in humans. There
was no mortality in any of 168 patients operated by
the trainees belonging to either group. There was no
significant difference in the serious adverse events pro-
portion (RR 0.36; 95% CI 0.02 to 8.43). None of the
trials reported patient quality of life or trainee satisfac-
tion. The operating time was significantly shorter (MD
6.50 minutes; 95% CI 10.85 to 2.15), the propor-
tion of patients discharged as day-surgery significantly
higher (RR 1.71; 95% CI 1.23 to 2.37) and the operat-
ing performance significantly better (SMD 0.84; 95%
CI 0.57 to 1.10) with supplementary box model training
compared to standard training.
Conclusions: Laparoscopic box-model training appears
to improve technical skills compared to standard surgi-
cal training in trainees with limited previous laparo-
scopic experience. However, the duration of the benefit
of box model training is not known. Further well
designed trials of low risk of bias and random errors
are necessary. Such trials should assess the long-term
impact of box model training on clinical outcomes and
compare box training with other forms of training.
PPH25-011
EXPERIENCE OF SINGLE UMBILICAL
PORT LAPAROSCOPIC IN THE
SPLEEN,LIVER AND GALLBLADDER
Zhiwei Sun, Jianzhong Tang, Yiwo Mo, Zhenghao Fei,
Xinyu Li and Chuncheng Meng
The First People’s Hospital of Yunnan Province, China
Introduction: Explore the feasibility of clinical applica-
tion of laparoscopy in hepatobiliary surgery through
the umbilical approach single hole.
Method: d in 10 mm, 10 mm trocar and a 5 mm trocar
core right-to-left, side-by-side. Electricity hook, ligasu-
er, straight cut intraperitoneal closure devices and other
equipment successfully completed surgery.
Results: 30–240 min successful completion of the sur-
gery, less bleeding, 2–10 days after hospital discharge,
and follow-up with no complications.
Conclusions: After the umbilical single port laparo-
scopic surgery is feasible and safe, minimally invasive,
quick recovery, beauty.
PPH25-012
BALLOON CATHETER COULD BE
SAFELY ADOPTED IN TACE FOR
PATIENTS WITH HYPOVASCULER
LIVER CANCER, A RANDOMIZED,
SINGLE-BLIND AND CONTROL TRIAL
WITH 178 CASES
Yong-bo Yang1, Yu-fang Chen2, Dong Chen3, Xing-an
Long3, Guo-liang Shao1 and Hong-yan Cheng3
1Zhejiang Cancer Hospital, China; 2Hangzhou First
People’s Hospital, China; 3Eastern Hepatobiliary
Surgery Hospital, China
Introduction: As the poor results of conservative TACE
treatment for patients with hypovasculer liver cancer,
we tried to adopt balloon catheter to gain more chemo-
therapeutic and embolic agents into the lesions. This is
the investigation on the safety of the original approach.
Method: Patients were divided into the experimental
and control group randomly. The experimental group
was treated with TACE by balloon catheter, while the
control group by the conventional catheter. The
enhanced CT or MRI examination and the laboratory
tests were adopted to evaluate its safety and efficacy by
the occurrence of adverse reactions and treatment
response during the follow-up.
Results: There were 89 cases in either group, showing
balanced baseline. The incidence of the gastrointestinal
adverse reactions in the control group was significantly
higher than that in the experimental group (p = 0.011),
which showed close relation to the bilateral emboliza-
tion and drug reflux, but had nothing to do with the
dose of lipiodol used in the TACE. There was no sig-
nificant difference in the laboratory parameters and the
liver function between the two groups in 1.5 months
after the TACE. The occurrence of the extrahepatic
metastasis in patients with tumor thrombus was signifi-
cantly earlier than that in patients without it
(p = 0.015, HR=2.535), though there was no significant
difference between the two groups. Meanwhile, the
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experimental group showed apparent advantage in the
dose of the lipiodol used in the TACE, the volume of
the intrapatic lipidol and early occurrence of partial
remission by the mRECIST (p = 0.016, 0.035, 0.029).
Conclusions: The applications of the balloon catheter
could reduce the regurgitation of chemotherapeutic
agents and lipiodol and did not show adverse effect to
patients’ liver function and extrahepatic metastasis. It
was preliminarily proved that balloon catheter could be
safely adopted in TACE for patients with hypovasculer
liver cancer, which also showed preferable effectiveness.
PPH25-013
SYNCHRONOUS ADENOCARCINOMA
AND MUCOSAL-ASSOCIATED
LYMPHOID TISSUE (MALT)
LYMPHOMA OF THE STOMACH
Wangjun Bu, Zhidong Wang, An Jiang, Yuanyuan Ji,
Baohua Li, Shu Zhang, Xiaoyan Guo and
Zongfang LI
the Second Affiliated Hospital, School of Medicine,
Xi’an Jiaotong University, China
Introduction: Gastric adenocarcinoma is one of the
most common malignancies, whereas primary gastric
lymphoma is relatively uncommon. The synchronous
occurrence of both gastric adenocarcinoma and malig-
nant gastric lymphoma in the same patient is extremely
rare. It is still controversial about their etiology. Recent
studies have suggested that not only gastric cancer but
also primary gastric lymphomas, especially those of
MALT type, are associated with Helicobacter pylori
infection.
Method: We report on a 48-year old male who was
referred to our hospital for complaining his epigastric
pain of 3 months duration. Endoscopic examination
revealed an elevated lesion located at pylorus, and the
biopsy demonstrated a moderate differentiated adeno-
carcinoma with superficial lamina muscularis invasion.
Results: The patient underwent total gastrectomy, and
the resected specimen revealed the presence of both
adenocarcinoma and MALT lymphoma. Immunohisto-
chemical staining showed positivity for LCA and CD20
in the infiltrated lymphoid cells. However, the lesion
with lymphoma was focal and smaller than that of ade-
nocarcinoma in size, which was different from that
most of the adenocarcinoma were smaller and pene-
trated less than coexisting MALT lymphoma reported
in literature.
Conclusions: It seemed to suggest that two lesions were
primly separate, but they integrated into a lesion for a
long time. Acknowledgements: This work was sup-
ported by a grant from Program for changjiang Schol-
ars and Innovative Research Team in University
(PCSIRT: 1171).
PPH25-014
THE SIGNIFICANCE OF SERUM
AMYLASE IN THE DIAGNOSIS OF
POST ERCP PANCREATITIS IN THE
ABSENCE OF ABDOMINAL PAIN
Nadeesha Nawarathna1, Dmgc Wijesundara1,
N Fernandopulle2, NMM Nawaratne2, P Jeans3 and
CAH Liyanage1
1Colombo North Teaching Hospital, Sri Lanka;
2National Hospital of Sri Lanka, Sri Lanka; 3Canberra
Hospital, ACT, Australia, Australia
Introduction: ERCP is an invasive pancreatico-biliary
investigation. Pancreatitis is a known complication fol-
lowing ERCP. In many units, Amylase and lipase levels
are routinely done to diagnose post ERCP pancreatitis.
Objective of this study is to assess the correlation
between serum amylase and abdominal pain following
ERCP and to describe the value of serum amylase in
diagnosing post ERCP pancreatitis.
Method: Consecutive 94 patients who underwent
ERCP at the NHSL and NCTH over a period of
6 months were included. Pre and serial post procedural
pain scores and amylase levels at 4 hrs and 24 hrs were
assessed. Abdominal pain was assessed using a pain
scale from 0 to 10. Data were analyzed by Minitab
software.
Results: A significant worsening of abdominal pain
was taken as an increase in the pain score of 3 units
post procedure compared to the pre procedure value.
22(27.5%) patients experienced a significant worsening
of pain at 4 hours and 7 (9.21%) experienced a signifi-
cant worsening of pain at 24 hours post procedure.
Out of 94 patients 44 patients (46.8%) had elevated
amylase at 4 hours post procedure. When significant
abdominal pain was cross tabulated against elevated
amylase,at 4 hours post procedure, the Chi square test
failed to show a significant association (p = 0.311).
Conclusions: Patients who undergo ERCP may develop
abdominal pain which regresses spontaneously in the
majority. Although many patients have elevated amy-
lase post procedure it does not have an association with
abdominal pain. Therefore a routine measurement of
amylase levels post procedure is of limited value.
PPH25-015
COST EFFECTIVE UTILIZATION OF
ENDOSCOPIC ACCESSORIES: IS
THERE ANY PLACE FOR “SCIENTIFIC
COMMON SENSE” IN TODAY’S
SCIENTIFIC WORLD?
Syed Mujahid Hassan
Sindh Institute of Urology and Transplantation, Pakistan
Introduction: In most of the developing countries it is
ultimately the patient who has to bear the higher cost
of endoscopic accessories (EAs), and consequently the
endoscopic procedures. The physicians always remain
in limbo whether to follow the scientific standards,
mostly set by the developed countries and consequently
depriving many patients of their treatment rights, or to
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adapt measures which apparently make sense to the sci-
entific minds but still awaiting scientific evidence, what
we may call it the “Scientific Common Sense” (SCS).
Method: Here are we presenting some of the examples
of SCS for the use of EAs to generate a debate whether
this concept has any place in today’s scientific world.
Results: Some of the disposable EAs can be used safely
again, on the same patient after proper cleaning and/or
re-sterilization. The esophageal multiband ligator is a
prime example which can be used multiple times after
reloading the bands thus reducing the cost to even less
than a quarter. Injectors are another example in this
category. Naso-biliary drains are prime example of
additional or innovative use as it may be cut into pieces
to make more than 25 biliary stents from the single
unit. Then there are EAs which can be re-sterilized to
the extent that they may be considered safe to use in
multiple patients, and this include various cannulae,
guide wires, biliary balloons, some type of retrieval bas-
kets and papillotomes etc. Then there are many acces-
sories which, by their very nature, may be considered
for use in there early expiry periods after reassuring
there mechanical and microbiological integrity.
Conclusions: These cost saving measures are in used
for decades in developing countries. Thus there is need
to re-evaluate whether SCS has any legitimate place in
today’s scientific world
PPH25-016
ENDOSCOPIC RETROGRADE
CHOLANGIOPANCREATOGRAPHY
VERSUS INTRAOPERATIVE
CHOLANGIOGRAPHY FOR DIAGNOSIS
OF COMMON BILE DUCT STONES
Kurinchi Gurusamy1, Vanja Giljaca2, David Higgie3,
Goran Poropat2, Davor Stimac2 and Brian Davidson1
1University College London and Royal Free Hospital,
United Kingdom; 2Clinical Hospital Centre Rijeka,
Rijeka, Croatia; 3North Bristol NHS Trust, United
Kingdom
Introduction: Endoscopic retrograde cholangiopancrea-
tography (ERCP) and intraoperative cholangiography
(IOC) are tests used in the diagnosis of common bile
duct (CBD) stones in patients suspected to have CBD
stones. There has been no systematic review of the
accuracy of ERCP and IOC.
Method: A literature search of MEDLINE, Embase,
Science Citation Index Expanded, BIOSIS, and Clini-
caltrials.gov until September 2012 was performed to
identifying studies assessing the diagnostic accuracy of
ERCP and IOC irrespective of language or publication
status, or whether data were collected prospectively or
retrospectively. At least two authors screened abstracts,
selected studies for inclusion, and collected data on true
positive, false positive, false negative, and true negative
from each study independently. Bivariate model was
used for combining the data.
Results: Five studies including 318 participants
reported the diagnostic test accuracy of ERCP. The
overall summary sensitivity and specificity of ERCP
was 0.8264 (95% CI 0.7276 to 0.8945) and 0.9794
(95% CI 0.9284 to 0.9943) respectively. Five studies
including 654 participants reported the diagnostic test
accuracy of IOC. The overall summary sensitivity and
specificity of IOC was 0.9882 (95% CI 0.7206 to
0.9996) and 0.9856 (95% CI 0.9590 to 0.9950) respec-
tively.
Conclusions: Some patients may have CBD stones in
spite of having a negative ERCP or IOC. Such people
may have to be retested if the clinical suspicion of
CBD stones is very high because of their symptoms.
Both these tests are fairly accurate in guiding further
invasive treatment as most people diagnosed to have
CBD stones by these tests have common bile duct
stones. Neither ERCP nor IOC should be used as refer-
ence standards in the assessment of accuracy of other
tests to diagnose CBD stones.
PPH25-017
UTILITY OF DIFFUSION-WEIGHTED
MAGNETIC RESONANCE IMAGING
FOR THE DETECTION OF
NEUROENDOCRINE TUMOR LIVER
METASTASES
Hans F. Schoellhammer, Joseph Kim, Gagandeep
Singh and Jinha Park
City of Hope National Medical Center, USA
Introduction: Accurate localization of neuroendocrine
tumors (NET) in the liver is essential for therapeutic
interventions. Since magnetic resonance imaging (MRI)
and diffusion weighted imaging (DWI) has improved
the detection of hepatic disease, our objective was to
evaluate the accuracy of DWI for assessing NET liver
metastases compared to standard contrast-enhanced
MR images.
Method: Patients with NET liver metastases were iden-
tified from 2010 to 2013 via institutional database
query. MR images of the liver acquired using 3 Tesla
magnets were reviewed. Conspicuity of the largest
lesion on DWI and T2-weighted imaging was catego-
rized (yes/no) and compared to conspicuity on con-
trast-enhanced images, which served as the control.
The sensitivity of DWI and T2 were calculated and
analyzed by McNemar’s test for paired data. Specificity
of DWI and T2 compared to contrast-enhanced images
in a separate negative control group without liver
metastases was determined.
Results: We identified 7 patients with NET liver metas-
tases with an average age of 59 years who underwent
14 MRI examinations that included DWI, T2, and con-
trast-enhanced imaging. When MRI images were
reviewed, lesion identification was better with DWI
compared to T2 imaging (n = 14 of 14, 100% vs. n = 7
of 14, 50%, respectively). A greater number of lesions
were identified by DWI than T2 sequences (p = 0.023),
and conspicuity by DWI was comparable to contrast-
enhanced imaging by McNemar’s test (p = NS). The
specificity of both DWI and T2 in the negative control
group of 22 exams from 13 patients was 100%.
Conclusions: MRI with DWI has increased sensitivity
over T2-weighted images for the detection of NET liver
metastases and is comparable to contrast-enhanced
images. DWI avoids the need for intravenous contrast
use and can be used for patients with contrast allergy
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or renal failure and is also superior to non-contrast
computed tomographic imaging. MRI with DWI
should be considered for routine evaluation of meta-
static NETs.
PPH25-018
THE APPLICATION OF ARFI IN LIVER
TUMORS
Chao-Wei Lee, Ming-Chin Yu, Yann-Sheng Lin,
Yi-Cheng Chen and Miin-Fu Chen
Chang Gung Memorial Hospital, Taiwan
Introduction: Liver cancers were usually screened by
liver sonography and diagnosed by dynamic imag-
ing.But sometimes it is still difficult to differentiate the
tumor characters. Acoustic radiation force impulse
(ARFI) was used to detect the degree of liver fibrosis, a
non-invasive method. Here we try to apply this diag-
nostic tool to depict the tumor characters.
Method: Patients with 50 HCC and 10 metastatic can-
cers were enrolled in this study, with median age of 53.
All were studied with ARFI before surgery or biopsy.
The tumor and nontumor parts stiffness measurements
were measured.
Results: The shear velocity measurement (SVM) of
ARFI was correlated with the liver fibrosis. Moreover,
the result showed significant difference between meta-
static tumor and hepatocellular carcinoma. Liver mets
showed significant higher SVM and less variation, com-
pared with HCC.
Conclusions: Our data showed ARFI, a non-invasive
and easy method, could offer important information
for liver tumors, primary or metastatic lesion, HCC or
adenocarcinoma. HCC cohort
PPH26-001
LAPAROSCOPIC INTRAOPERATIVE
ULTRASONOSCOPY IN PATIENTS
WITH CHOLEDOCHOLITHIASIS
Kristaps Atstupens, Vladimirs Fokins, Haralds Plaudis,
Maksims Mukans and Guntars Pupelis
Riga East Clinical University Hospital Gailezers, Latvia
Introduction: Laparoscopic ultrasonoscopy is a novel
promising alternative to preoperative examination of
the bile ducts in the case of suspected choledocholithia-
sis. The aim of study was to evaluate the diagnostic
efficiency of laparoscopic intraoperative ultrasonoscopy
(LUS) in patients with suspected choledocholithiasis.
Method: Totally 124 patients urgently admitted with
suspected choledocholythiasis were candidates for intra-
operative ultrasonoscopy and prospectively were
included during the period from August 2012 till June
2013. Inclusion criteria were preoperative dilatation of
the bile ducts on transabdominal ultrasound, biliary
pancreatitis/cholangitis, elevated liver enzymes and/or
bilirubin. All patients underwent laparoscopic cholecys-
tectomy and LUS. Visualization of macro-/ microlithia-
sis was considered as a positive finding. Pre-operative
variables significant for cholestasis were compared in
patients with positive or negative LUS findings.
Results: Preoperatively choledocholithiasis was sus-
pected in 86 patients. Diagnose was based on transab-
dominal ultrasound findings and elevated liver enzymes
and/or bilirubin level. Only in 45 cases (52.3%) LUS
confirmed preoperative diagnose. In 38 patients preop-
erative diagnose was proved by magnetic resonance
imaging (11cases), contrast enhanced computer tomog-
raphy (3cases) or transabdominal ultrasound in 24
cases. LUS confirmed preoperative diagnose of 32
patients, 84.2%. Preoperative variables were compared
in patients with positive or negative LUS finding (77
patients) and (47 patients). Median level of total and
direct bilirubin were significantly higher in patients with
positive LUS finding, 52 (IQR 93 – 23) versus 22 (44 –
11) lmol/L and 41 (74 – 12) versus 11 (30 – 4) lmol/L
compared to patients with negative LUS finding,
p < 0.001, respectively. Significantly larger common
bile duct in LUS positive patients was another finding
10 (12 – 7.3) versus 7 (9.2 – 6) mm, p < 0.001, respec-
tively.
Conclusions: LUS is efficient, fast and accurate proce-
dure for detecting stones or sludge in patients with pro-
ven or suspected choledocholithyasis. Large common
bile duct and elevated bilirubin increases risk of chole-
docholithiasis.
PPH26-002
DEVELOPMENT OF SCIENTIFIC
INITIATION IN MEDICAL EDUCATION:
PRELIMINARY RESULTS OF THE
STUDENTS’ PERSPECTIVE
Maria Clara Camargo Traldi1, Angelo So Taa Kum1,
Jessica Okubo1, Ana Gabriela Vivarelli Fernandes1,
Fernando Chuluck Silva1, Joel Avancini Rocha Filho2,
Estela Regina Ramos Figueira3, Eleazar Chaib3, Jose
Otavio Costa Auler Jr2 and Luiz Augusto Carneiro
D’Albuquerque3
1Scientific Research in Medicine, Brazil; 2Discipline of
Anesthesiology, Brazil; 3Discipline of Liver and Digestive
Organ Transplantation, Brazil
Introduction: In Medical Schools of higher intellectual
potential, Scientific Initiation (SI) is considered essen-
tial to improving students’ skills, creativity and respon-
sibilities that magnify the academic life, contributing
positively to medical practice. Although many steps for
the establishment of SI programs were overcome, many
students still fail participate research programs. We
aimed to evaluate experiences and perceptions of medi-
cal students related to their participation in SI projects.
Method: This is a descriptive exploratory study per-
formed at Faculdade de Medicina da Universidade de
Sao Paulo and Faculdade de Ciencias Medicas da
Santa Casa de Sao Paulo. We evaluated students
attending the first to the third year of medical school in
2013 through application of a questionnaire of multiple
choices. There were included students over 18 who sign
the acceptance form to participle in the study. We
assessed the interest, the barriers, and expectations of
the students in respect to SI.
Results: We evaluated 348 students, 38% reported par-
ticipation in activities associated with scientific
research. In most cases, students joined SI programs by
indication of friends and teachers. Twenty-seven stu-
dents (20%) had research SI grants, 15 from FAPESP,
© 2014 The Authors
HPB © 2014 Americas Hepato-Pancreato-Biliary Association HPB 2014, 16 (Suppl. 2), 385–405
398 Poster Panel [HPB]
8 from CNPQ and 4 from USP. Of the 62% of stu-
dents who reported never having participated in SI pro-
jects, 90% are interested in participating and believe
the institution should invest more in such programs.
The main reasons for not being involved in a research
program were lack of knowledge in 74% and deficiency
of appropriate orientation in 50%.
Conclusions: These preliminary results showed that stu-
dents have great interest in participate SI programs and
understand the importance of SI in medical education.
The main reasons for not to be enrolled in SI programs
appear to be related with lack of knowledge and orien-
tation about how to initiate the SI program.
PPH26-003
CHANGING PARADIGMS IN BILE
CULTURE MICROFLORA AND
EMERGENCE OF MULTIDRUG
RESISTANT ORGANISMS WITH THEIR
CLINICAL IMPLICATIONS
Rohit Gaurav1, Sudeep Banerjee1, Manas Roy2
and Sanjay Bhattacharya2
1TATA Medical Center, India; 2TATA Medical Center,
Kolkata, India
Introduction: There has been an emergence of resistant
micro-organisms across the board with their clinical
implications. Understanding the epidemiology of organ-
isms with sensitivity patterns encountered in bile of
malignant Hepato-pancreatico-biliary (HPB) patients is
important for optimal infection management and con-
trol in postoperative period.
Method: We did retrospective analysis of prospectively
maintained electronic database of patients who under-
went Hepato-biliary surgery with concomitant bile duct
excision. An intraoperative bile culture / biliary stent
were sent in all such cases with antibiogram. Parame-
ters like age, sex, BMI, duration between stenting and
surgery, albumin were studied.
Results: All patients (n = 33) who underwent HPB sur-
gery with bile duct excision from October 2011 to July
2013 were included in the study. Intraoperative bile
was collected and sent for culture sensitivity. Biliary
stents were also sent in those patients with prior biliary
decompression. Pancreaticoduodenectomy (82%)
formed the majority of cases. Mean age was 58.5 years
(38–73 years) with a male to female ratio of 20:13. 22
(66.7%) patients had preoperative biliary decompres-
sion with plastic stent being commonest. Bile in 9
(27.3%) patients was sterile. Out of these 9 patients,
one had plastic biliary stent and one had external PTB
drainage. 3 patients who did not have any preoperative
biliary decompression grew organisms, none having
MDRO. Most common organisms isolated were E coli
(25%), Klebsiella (22.9), Enterococcus faecium (14.6)
and Enterococcus faecalis (9%). Multi drug resistant
rate was 45.5% (20/44) with ESBL E coli being com-
monest (50%).
Conclusions: High incidence of MDRO suggests an
alteration of ambient microbiological flora. This calls
for developing indigenous prescription policies for anti-
microbial prophylaxis. Amikacin was sensitive against
most of the drug resistant organisms.
PPH26-004
ERCP, SPHINCTEROTOMY AND
LARGE BALLOON
SPHINCTEROPLASTY FOR THE
MANAGEMENT OF
CHOLEDOCHOLITHIASIS, A SINGLE
CENTRE EXPERIENCE
George Kalogeropoulos, Daniel Rayzan, Immanual
Henry, Adrian Fox, Aloysius Chee, Simon Ho, Sean
Mackay, Sayed Hassen, Simon Banting and Richard
Cade
Eastern Health, Box Hill Hospital, Australia
Introduction: Balloon dilatation of the ampulla of
Vater (sphincteroplasty) at Endoscopic Retrograde
Cholangio-Pancreatography (ERCP) is an invaluable
procedure in the management of large bile duct stones.
For extraction of large bile duct stones at our institu-
tion, patients have traditionally had an ERCP with
sphincterotomy initially and a balloon sphincteroplasty
at a subsequent procedure due to concerns of perfora-
tion.
Method: A retrospective review of all patients undergo-
ing ERCP and large balloon dilatation for choledocho-
lithiasis between 2010–2013 was performed. Outcomes
measured included successful stone extraction, compli-
cations, degree of dilatation performed and stone size.
A subset of patients who had concurrent sphincteroto-
my and balloon sphincteroplasty was also identified.
Results: In total 129 ERCPs were performed with bal-
loon sphincteroplasty. 102 had a previous sphincteroto-
my and thus underwent dilatation alone. Success in
clearing the bile duct was 76.47% with the most com-
mon dilatation size being 10 mm (65.38%), range (8–
18 mm). The most frequent stone size extracted was
10–20 mm (41.03%). There were 6 (5.88%) complica-
tions (5 bleeding and 1 oesophageal perforation). There
were 27 patients who underwent sphincterotomy and
immediate dilatation. The success rate in clearing the
bile duct was 88.9% cleared with 1 complication
(3.7%) (bleeding). The most frequent stone size
extracted was 5–10 mm (41.67%) with the most com-
mon dilatation performed being 10 mm (45.83%),
range (8–18 mm).
Conclusions: Performing both a sphincterotomy and
immediate balloon dilatation had a high success rate in
extracting bile duct stones, although the average stone
size extracted was smaller than in the delayed dilatation
alone group. The complication rates for both groups
were similarly low suggesting that sphincterotomy and
immediate balloon dilatation is safe and effective for
retrieval of CBD stones. This approach may avoid the
need for repeat ERCP and we are planning to investi-
gate this at our institution with a randomized con-
trolled trial.
© 2014 The Authors
HPB 2014, 16 (Suppl. 2), 385–405 HPB © 2014 Americas Hepato-Pancreato-Biliary Association
Poster Panel [HPB] 399
PPH26-005
CLINICAL IMPLICATION OF ZEB-1
AND E-CADHERIN EXPRESSION IN
HEPATOCELLULAR CARCINOMA
(HCC)
Motoyuki Hashiguchi, Sinichi Ueno, Masahiko
Sakoda, Satoshi Iino, Kiyokazu Hiwatashi, Yuko
Mataki, Kosei Memura, Hiroshi Kurahara, Hiroyuki
Shinchi and Syoji Natsugoe
Kagoshima University, Japan
Introduction: While recent research has shown that
expression of ZEB-1 in a variety of tumors has a cru-
cial impact on patient survival, there is little informa-
tion regarding ZEB-1 expression in hepatocellular
carcinoma (HCC). This study investigated the co-
expression of ZEB-1 and E-cadherin in HCC by immu-
nohistochemistry and evaluated its association with
clinical factors, including patient prognosis.
Method: A total of 108 patients with primary HCC
treated by curative hepatectomy were enrolled. ZEB-1
expression was immunohistochemically categorized as
positive if at least 1% cancer cells exhibited nuclear
staining. E-cadherin expression was divided into pre-
served and reduced expression groups and correlations
between ZEB-1 and E-cadherin expression and clinical
factors were then evaluated.
Results: With respect to ZEB-1 expression, 23 patients
were classified into the positive group and 85 into the
negative group. Reduced E-cadherin expression was
seen in 44 patients and preserved expression in the
remaining 64 patients. ZEB-1 positivity was signifi-
cantly associated with reduced expression of E-cadherin
(p = 0.027). Moreover, significant associations were
found between ZEB-1 expression and venous invasion
and TNM stage. ZEB-1 positivity was associated with
poorer prognosis (p = 0.025). Reduced E-cadherin
expression was significantly associated with intrahepatic
metastasis and poorer prognosis (p = 0.047). In partic-
ular, patients with both ZEB-1 positivity and reduced
E-cadherin expression had a poorer prognosis
(p = 0.005). Regardless of E-cadherin status, ZEB-1
was not a significant prognostic factor by multivariate
analysis. There was no statistical difference in overall
survival when E-cadherin expression was reduced in the
ZEB-1 positive group (p = 0.24).
Conclusions: Positive ZEB-1 expression and loss of E-
cadherin expression are correlated with poor prognosis
in HCC patients and malignancy of ZEB-1 positive
tumors involves EMT.
PPH26-006
EDUCATION FOR RESIDENTS TO
SAFELY PERFORM
PANCREATODUODENECTOMY
Junichi Yoshikawa1, Yoshiharu Shirakata1, Atsuhiko
Maki1 and Yoshifumi Mizuno1
1Hyogo Prefecutural Amagasaki Hospital, Japan
Introduction: The world is now facing a shortage of
surgeons. Young surgeons are encouraged to become
independent as early as possible. Independent surgeons
have to safely perform difficult procedures like pancre-
atoduodenectomy (PD). We will focus on whether we
educate residents to safely perform PD.
Method: We have standardized our PD procedure and
the way of placing drains originated by two experi-
enced surgeons. Since 2006, we have educated residents
at postgraduate year 3–7 to perform PD supervised by
the two surgeons. This study retrospectively analyzed
56 supervised PD cases between 2001 and 2013. The
operators of PD were classified into two groups: resi-
dent (postgraduate year 3–7) or non-resident (postgrad-
uate year ≥8). We chiefly investigated short-term
morbidity, the rate of reoperation, and hospital mortal-
ity.
Results: There were 7 operators (16cases) in the resi-
dent group and 6 operators (40 cases) in the non-resi-
dent group. Mean (standard deviation) duration since
graduation for operators was 5.38 (0.88) years and
17.5 (4.93) years in the resident group and in the
non-resident group, respectively. Overall morbidity was
a little lower in the resident group (56.3% vs. 72.5%;
p = 0.24). No significant differences were observed
between the resident group and the non-resident group,
in the rate of pancreatic fistula classified as Grade B or
C by the International Study Group on Pancreatic Fis-
tula (37.5% vs. 35%; p = 0.86) and in the rate of severe
complications classified as Grade IIIa or over by the
Clavien-Dindo classification (0% vs. 2.5%; p = 0.52).
The same reoperation rates (both 0%) and hospital
mortalities (both 0%) were seen in both groups.
Conclusions: Outcomes in the resident group proved
acceptable compared with those in the non-residents
group. Standardization of both PD procedure and
postoperative drainage system enables us to educate
residents to safely perform PD.
PPH26-007
HYPOXIA INDUCIBLE FACTOR-1
ALPHA (HIF-1a) EXPRESSION UNDER
HYPOXIA PLAYS A KEY ROLE IN
INVASION AND METASTASIS VIA
EPITHELIAL-MESENCHYMAL
TRANSITION (EMT) IN CD133-
EXPRESSION PANCREATIC CANCER
Sonshin Takao, Koichirou Tsukasa, Koki Maeda,
Qiang Ding, Yuko Mataki, Kousei Maemura, Hiroshi
Kurahara, Hiroyuki Shinchi and Shoji Natsugoe
Kagoshima University, Japan
Introduction: Pancreatic cancer (PC) is a highly lethal
disease which is the fifth leading cause of cancer related
death in Japan. CD133 is well known as one of cancer
stem cell (CSC) markers of PC. We previously reported
that CD133 expression in PC is correlated with poor
prognosis and lymph node metastasis (Br J Cancer,
2008). However, the role of CD133 in CSCs is still
obscure. On the other hand, PC is surrounded with
desmoplastic morphology which is under the low oxy-
gen condition because of its insufficient blood supply.
In this study, we hypothesized that HIF-1a expression
under hypoxia plays a key role in invasion and metas-
tasis for CD133+ PC.
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Method: 1) To investigate the relationship between
HIF-1a and CD133 expression in PC, primary tumor
tissues were used for immunohistochemical study. 2)
To clarify the mechanism, we established a highly
migratory CD133+ Capan1M9 cells (Human Cell,
2012). Consequently, we established Capan1M9-GFP-
shCD133 (CD133knockdown) cells by lentiviral transduc-
tion method. Using these cell lines, wound healing
assay, immunofluorescence staining, western blot, and
real-time RT-PCR were performed.
Results: Immunohistochemical studies: 1) CD133 expres-
sion significantly correlated with poorer prognosis in
clinical PC. 2) HIF-1a expression significantly corre-
lated with hepatic metastasis in clinical PC. In vitro
studies: 1) Hypoxia increased the ratio of CD133+ cells
by FACS analysis. 2) CD133+ cells showed higher
expression of HIF-1a than CD133knockdown cells. 3)
Under hypoxia, migration ability of CD133+ cells was
higher than that of CD133knockdown cells by wound
healing assay. 4) EMT-related molecules such as Slug,
N-cadherin and fibronectin in CD133+ cells were
higher than those in CD133knockdown cells.
Conclusions: Our results indicated that HIF-1a expres-
sion under hypoxia stimulates invasion and metastasis
in CD133 + PC cells through EMT. The elucidation of
role of HIF-1a in CD133 + PC may provide a new
insight for PC metastasis.
PPH26-008
DEVELOPMENT OF A NEWLY
DESIGNED BILIARY INTERNAL
FISTULA TUBE FOR ENDOSCOPIC
TRANSLUMINAL BILIARY DRAINAGE
Masayasu Aikawa, Mitsuo Miyazawa, Yukihiro
Watanabe, Katsuya Okada, Kojun Okamoto, Kiyoka
Hara and Isamu Koyama
Saitama Medical University, International Medical
Center, Japan
Introduction: We developed a biliary internal fistula
tube (BIFT) which has been constructed with a conven-
tional biliary stent tube and a bioabsorbable polymer
seat (BAPS) for a transluminal biliary drainage. In this
study we attempted to investigate the difference
between the BIFT and conventional tube (CT) in bili-
ary-enteric fistula formation.
Method: The BIFT is a conventional biliary tube
wrapped with the BAPS, which is 0.5 mm thickness.
The BAPS is an ideal scaffold for tissue regeneration
with porous property to allow easy penetration of cells.
BIFT group (n = 3): The pigs were laparotomized to
expose the extrahepatic bile duct (EHBD). The 5 cm
BIFT was placed between gallbladder (GB) and duode-
num (DU). CT group (n = 3): The 5 cm CT was placed
between GB and DU in a similar manner of the BIFT
group. In both group these pigs were sacrificed and re-
laparotomized at 4 weeks after the placement.
Results: BIFT group: At 4 weeks after the placement,
the distance between GB and DU was shortened. A bil-
iary-enteric fistula, which had 1.5 cm bore diameter
and 2 cm length, was constructed between GB and
DU. CT group: At 4 weeks after the placement, the CT
became surrounded by connective tissue, and the dis-
tance between GB and DU came closer to each other.
However, the connective tissue between GB and DU
was fragile and easy to be divided. The lumen of the
CT has biliary sludge and almost became obstructed.
Conclusions: The placement of the BIFT between GB
and DU induced rapid and good fistulization, and has
the potential for application as a novel device for trans-
luminal biliary drainage avoiding the need for exchange
of tubes.
PPH26-009
PANCREAS PRESERVING SURGERY
FOR PRIMARY ADENOCARCINOMA OF
THE DISTAL DUODENUM; REPORT OF
A CASE AND LITERATURE REVIEW
Hiroyuki Baba1, Yuichiro Watanabe1, Hideyuki Ishida1
and Minoru Tanabe2
1Saitama Medical Center, Japan; 2Tokyo Medical and
Dental University, Japan
Introduction: Primary adenocarcinoma of the distal
duodenum (PADD) is a rare entity. We report a case
of PADD which extended to jejunum without involving
pancreas and major mesenteric vessels.
Method: 77 year-old-man experienced shortness of
breath and fatigue for few months. He visited nearby
hospital for examination and was diagnosed as having
anemia. CT scan revealed a mass measuring 7 cm in
length at the distal duodenum. Hypotonic duodenogra-
phy showed “apple core sign” at forth portion of the
duodenum. Endoscopy was carried out to find almost
complete obstruction of the lumen and the biopsy spec-
imen was conclusive for moderately differentiated ade-
nocarcinoma. As magnetic resonance imaging showed
expansive growth with less chance of pancreatic head
involvement, we carried on to perform resection of the
third and forth portions of the duodenum (distal duo-
denectomy).
Results: Functional end to end anastomosis was possi-
ble between the remnant duodenum and jejunal limb.
No evidence of lymph node metastases or local inva-
sion was detected pathologically.
Conclusions: Pancreatic preserving resection can be
applied to PADD if invasion to the pancreas is ruled
out. If not, pancreaticoduodenectomy is preferred for
better prognosis.
PPH26-010
PROGRAM DIRECTORS’
PERSPECTIVES ON COMPLIANCE AND
COMPETENCY WITH ACGME
HEPATOPANCREATICOBILIARY
REQUIREMENTS FOR GENERAL
SURGERY RESIDENCY
Vijay Mittal, Khortnal Delvecchio and Lauren
Smithson
Providence Hospital and Medical Centers, USA
Introduction: Hepatopancreaticobiliary (HPB) experi-
ence in general surgery residency is changing. This
study aimed to compare the methods by which the
Accreditation Council for Graduate Medical Educa-
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tion’s (ACGME) HPB requirements are met in general
surgery residency. Secondary objectives included deter-
mining who performs HPB surgery and which aspects
of diagnostic techniques are employed to enhance HPB
education.
Method: A thirty-question survey was sent out to 241
general surgery program directors (PDs) via email.
Analysis of the responses was completed.
Results: Academic and mixed programs made up a
majority of the responders. Fifty percent of these pro-
grams did not have any HPB-fellowship-trained sur-
geons, resulting in HPB cases being performed by
general surgeons (30%) or surgical oncologists (35%).
Regarding residency training, 83% of HPB cases were
performed by teaching faculty at the institution; only
5% of programs sent residents to tertiary centers to
achieve their required ACGME numbers. Most chief
residents were completing 50–75% of each HPB case,
but only 50% of PDs felt that graduating residents
were competent to perform HPB surgery after gradua-
tion. Most PDs (59%) stated that none of their chief
residents were entering into an HPB fellowship. More
PDs believed that single most important diagnostic
ability for HPB practice is intraoperative ultrasound
interpretation (60%) rather than upper endoscopy
(40%). Training for these diagnostic skills was per-
formed by general surgeons (79% of programs), with
endoscopy simulation available in 74%. Clinical
research was more common (58%), with only 30% of
programs having basic science labs.
Conclusions: General surgery residency is changing,
with more specialization and less autonomy for resi-
dents. More investments into simulation and training
should be initiated in order to improve skill sets and
expand diagnostic abilities. Enhancing residents’ abili-
ties in HPB is key to meeting the ACGME require-
ments for training and to graduate competent general
surgeons.
PPH26-011
AN APPRAISAL OF LIVER RESECTION
AND THROMBECTOMY FOR
HEPATOCELLULAR CARCINOMA
WITH TUMOR THROMBI EXTENDING
TO MAJOR MAIN PORTAL VEIN
Cheng-Chung Wu1 and John Wang1
1Taichung Veterans General Hospital, Taiwan
Introduction: The prognosis of hepatocellular carci-
noma (HCC) with gross tumor thrombi (TT) including
portal vein is usually poor. When TT extended to
major portal vein (portal bifurcation or main portal
vein), the prognosis is extremely poor. Transarterial
chemoembolization (TACE) or liver transplantation is
always unrecommended due to rich of liver failure or
early cancer recurrence. The aim of the study is to eval-
uate the benefit of liver resection and TT removal.
Method: A retrospective review of 85 liver resections
for newly diagnosed HCC with tumor thrombi extend-
ing to major portal vein between 1991 and 2012 was
conducted. In the similar time, 2094 major hepatec-
tomy, liver resection for HCC were performed. The
patients’ age was 64.8 + 12.9 (range 21 – 86 yrs) (right
or extended right hepatectomy, left or extended left
hepatectomy) were performed on 48 patients. Partial
hepatectomies with TT removal were performed on the
other 37 patients due to less favorable liver function.
Results: Postoperative complication occurred in 22
patients (25.8%) without 90-day postoperative mortal-
ity. Five-year disease-free and overall survival rates are
21.6% and 26.4%, respectively. No difference of sur-
vival rates would be seen in major hepatectomy and
partial hepatectomy. After univariate and multivariate
analysis only tumor size >10 cm had a poorer progno-
sis <10 cm (p < 0.0001). The longest disease-free and
overall survival time in this series is 19 years.
Conclusions: Liver resection with partial portal vein
thrombi removal may provide possible cure for HCC
with tumor thrombi extending to major portal vein.
However, adjuvant therapies should be considered
when tumor size is >10 cm.
PPH26-012
COST-EFFECTIVENESS ANALYSIS IN
MANAGEMENT OF REFRACTORY
ASCITES: PRELIMINARY STUDY
Luciana Haddad, Wellington Andraus, Anto^nio Turri,
Tatiana Conte, Bernardo Canedo and Luiz Augusto
Carneiro D’Albuquerque
S~ao Paulo University, Brazill
Introduction: Ascites is one of the most common com-
plications of cirrhosis and it indicates that the disease is
at an advanced stage. In cirrhotic patients with refrac-
tory ascites, treatment is based on repeat paracentesis.
The objective of the study is to evaluate the cost of
outpatient treatment of refractory ascites in cirrhotic
patients.
Method: A prospective study was done, including all
patients with cirrhosis who underwent paracentesis
from March 2012 to March 2013 at the Hospital of
S~ao Paulo University in the Outpatient Service of Liver
Transplantation Unit. A micro cost analysis was per-
formed with tab individual data regarding the con-
sumption of albumin, drugs, materials, human
resources, and laboratory analysis; and also the clinical
data of the patients.
Results: We conducted a total of 881 paracentesis in
166 patients, 60.6% men and 39.5% women. Patients
underwent an average of 5.3 paracentesis / year (1–32).
The total cost was $156.9; and the main cost compo-
nent was albumin ($83.9). The total volume of ascites
drained was 7396 liters. The average cost per procedure
was $155.2  57. The most frequent causes of cirrhosis
were hepatitis C (32%) and alcohol (20%). The major-
ity of patients were enrolled in the waiting list for liver
transplantation (54.2%). The factors statistically related
to an increased cost during this period were drained
fluid volume (p < 0.001), MELD score higher than 24
(p < 0.001) and patients in transplant waiting list
(p < 0.001).
Conclusions: Patients with refractory ascites treated
with paracentesis represent a high cost group in health
services. The main factors related to the cost are the
volume of fluid drained, due to the need for albumin
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replacement and severity of liver disease according to
MELD. These data are being used to study the cost-
effectiveness of liver transplantation for patients with
refractory ascites and low MELD score.
PPH26-013
POSTOPERATIVE ADJUVANT TACE
CAN PREVENT THE EARLY
OCCURRENCE OF LUNG METASTASIS
IN HIGH-RISK PATIENTS
Yong-bo Yang1, Yu-fang Chen2, Guo-liang Shao1,
Xing-an Long3 and Hong-yan Cheng3
1Zhejiang Cancer Hospital, China; 2Hangzhou First
People’s Hospital, China; 3Eastern Hepatobiliary
Surgery Hospital, China
Introduction: To investigate the risk factors for the
early occurrence of lung metastasis after surgery and
whether patients could benefit from the postoperative
adjuvant TACE.
Method: A total of 284 patients that were diagnosed
with hepatocellular carcinoma in the postoperative
pathology and detected lung metastasis during the fol-
low-up were analyzed respectively. Calculate the cumu-
lative incidence of lung metastasis for different risk
factors by the Kaplan-Meier method. All 21 possible
risk factors, including preoperative laboratory tests,
imaging findings, and postoperative pathology, were
entered into the COX regression model for univariate
analysis and followed by multivariate analysis. Then
compare the difference of the time to lung metastasis
between patients with or without adjuvant TACE by
the Log-rank test.
Results: Maximum diameter of tumor ≥10 cm, multifo-
cal lesions and merging tumor thrombosis in preopera-
tive imaging findings, and incomplete or absent tumor
capsular, larger necrosis and merging satellite lesions in
postoperative pathology were significant high risk fac-
tors for lung metastasis in patients with HCC after sur-
gery by COX univariate and multivariate analysis.
193 patients adopted adjuvant TACE treatment after
surgery. The median time to lung metastasis in patients
with adjuvant TACE in high-risk patients was 7 (5.72,
8.28) months while those without adjuvant TACE was
4 (2.70, 5.30) months (p = 0.010). However, there was
no significant difference in non-high-risk patients with
[12 (9.39, 14.61) months] or without [13 (6.30, 19.71)
months] adjuvant TACE (p = 0.676).
Conclusions: Postoperative adjuvant TACE can prevent
the early occurrence of lung metastasis in high-risk
patients that indicated by preoperative imaging and
postoperative pathology.
PPH26-014
APPLICATION OF ADAPTIVE
STATISTICAL ITERATIVE
RECONSTRUCTION CAN IMPROVE
THE DIAGNOSIS CONFIDENCE OF
SMALL HEPATOCELLULAR
CARCINOMA IN MONO-ENERGY
IMAGES BY SPECTRAL CT
Yu-fang Chen1, Yong-bo Yang2, Yan-zhuo Li3, Na
Gao4, Wen-hui Chen1 and Hong-yan Cheng3
1Hangzhou First People’s Hospital, China; 2Zhejiang
Cancer Hospital, China; 3Eastern Hepatobiliary Surgery
Hospital, China; 4GE China, China
Introduction: To investigate whether Adaptive Statisti-
cal Iterative Reconstruction (ASIR) can improve the
quality of mono-energy images by spectral CT.
Method: The mono-energy images by spectral CT (Dis-
covery 750, GE) of 23 patients with small hepatocellu-
lar carcinoma (SHCC) that confirmed by postoperative
pathology were studied retrospectively. 13 cases (group
1) were reconstructed with ASIR while 10 cases (group
2) without ASIR. Measure the difference of CT value
(CTD) between the lesions and normal liver paren-
chyma and the standard deviation of normal liver
parenchyma (SD) in the mono-energy images on
40~140 keV during the arterial, portal vein and delayed
phase (AP, PVP and DP). Then calculate the contrast
noise ratio (CNR, the ratio of CTD and SD). Compare
CTD, SD, and CNR on 40~140 keV between patients
in group 1 and group 2 by t Test. The diagnosis confi-
dence (1~5) of SHCC in the two groups was evaluated
by two high-seniority doctors.
Results: There was no significant difference in CTD on
40~140 keV during the triple phases. The SD in group
1 was significantly lower than that in group 2 on 40~
90 keV during AP and PVP, and on 40~100 keV dur-
ing DP. The mean optimal CNR was 68.72 keV during
AP, 69.88 keV during PVP and 71.06 keV during DP.
The CNR in group 1 was significantly higher than that
in group 2 on 50~90 keV during AP, on 60~100 keV
during PVP and on 40~90 keV and 110 keV during
DP. The diagnosis confidence in group 1 was signifi-
cantly higher than that in group 2 on 50~80 keV during
AP, on 60~80 keV during PVP and on 50~90 keV dur-
ing DP.
Conclusions: The application of ASIR can improve the
quality of mono-energy images by lowering the SD and
increasing the CNR, especially on 60~90 keV, which
may raise the diagnosis confidence of SHCC.
PPH26-015
FULLY COVERED SELF-EXPANDABLE
METAL STENTS FOR TREATMENT OF
BENIGN BILIARY STRICTURES: A
META-ANALYSIS
Jun Wu, Ya-min Pan, Tian-tian Wang and Bing Hu
Eastern hepatobiliary surgery hospital, China
Introduction: Endoscopic stenting has been suggested
as the main method of treating benign biliary strictures
(BBSs), usually managed with multiple plastic stents
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placement. Recently, fully covered self-expandable
metal stents (FCSEMSs) have been increasingly pro-
posed as a newly alternative for treating BBSs. We
aimed to assess the efficacy and safety of FCSEMS in
treating BBS by pooling data of existing trials.
Method: Databases including PubMed, EMBASE, and
the Science Citation Index were searched and evaluated
by two reviewers (J.W and B.H) independently. Studies
pertinent to FCSEMSs for treatment of benign biliary
strictures were included without restriction of language.
Reviews, comments, case reports (less than 10 patients)
were excluded. Main Outcome Measurements included
stricture resolution rate, stricture recurrence rate and
overall complications. All statistical analyses were done
using STATA (Statacorp Version, 12.0, USA). Pooling
data was conducted in a fixed effect model or a random
effects model.
Results: Eleven studies involving 313 patients (Male,
72%; post-LT anastomotic strictures, 40.8%) were ana-
lyzed. The stricture resolution rate was 90% of all
patients (95% CI, 0.84–0.95) (Fig. 1) after an average
stenting duration of 5.2 months. The stricture recur-
rence rate was 6% of all patients (95% CI, 0.03–0.09)
(Fig. 2) after a median follow up of 12.5 months. The
overall complications were 27% (95% CI, 0.12–0.41)
(Fig. 3).
Conclusions: Endoscopic placement of FCSEMS is an
effective, promising modality for management of
patients with benign biliary strictures, while it was asso-
ciated with high complications. Prospective controlled
trials need doing to determine whether it is superior to
traditional multiple plastic stents treatment.
PPH26-016
PRIMARY TUBERCULOSIS OF THE
APPENDIX: A RARE CAUSE OF A
COMMON DISEASE
Vinay H G, Sharath Chandra B J and Girish T U
Medical Council of India, India
Introduction: Tuberculosis (TB) is a major public
health problem in developing countries like India. India
accounts for one-fifth of the global TB incident cases.
Gastrointestinal TB accounts for 3% of extra pulmo-
nary TB, the commonest site of involvement being the
ileocaecal region. However involvement of the appen-
dix, lying so close to the ileocaecal region is rare. Pri-
mary tuberculosis of the appendix presenting as
appendicular abscess is even rarer with incidence of 0.1
to 0.6%. The pathogenesis of this isolated lesion is not
clear and presentations are varied. Because of its rarity
and absence of any specific clinical and radiological
finding, diagnosis is made only after histopathological
examination of the appendectomy specimen.
Method: Tuberculosis (TB) is a major public health
problem in developing countries like India. India
accounts for one-fifth of the global TB incident cases.
Gastrointestinal TB accounts for 3% of extra pulmo-
nary TB, the commonest site of involvement being the
ileocaecal region. However involvement of the appen-
dix, lying so close to the ileocaecal region is rare. Pri-
mary tuberculosis of the appendix presenting as
appendicular abscess is even rarer with incidence of 0.1
to 0.6%. The pathogenesis of this isolated lesion is not
clear and presentations are varied. Because of its rarity
and absence of any specific clinical and radiological
finding, diagnosis is made only after histopathological
examination of the appendectomy specimen.
Results: Because of its rarity and absence of any spe-
cific clinical and radiological finding, diagnosis is made
only after histopathological examination of the appen-
dectomy specimen. Hence all appendicectomy speci-
mens need to be examined in order to prevent serious
complications.
Conclusions: Because of its rarity and absence of any
specific clinical and radiological finding, diagnosis is
made only after histopathological examination of the
appendectomy specimen. Hence all appendicectomy
specimens need to be examined in order to prevent seri-
ous complications.
In our review of 229 cases, for 4 years, we report our
experience with tuberculous appendicitis in a tertiary
centre in a nation where tuberculosis is still endemic.
PPH26-017
SPONTANEOUS DIAPHRAGMATIC
RUPTURE: A RARE CAUSE FOR
GASTRIC OUTLET OBSTRUCTION
Vinay H G, Shivakumar M and Shivakumar S
Medical Council of india, India
Introduction: Acute gastric obstruction associated with
a non-congenital diaphragmatic hernia is rare.
Obstructed diaphragmatic hernia causes severe respira-
tory distress and cardiovascular compromise and need
to operate urgently. Because of the infrequency of com-
plete obstruction of a diaphragmatic hernia and the dif-
ficulties in diagnosis, we report this case.
Method: A 35 year old male presented with left sided
chest pain and dyspnea. Patient later developed spas-
modic type of abdominal pain with non-bilious, projec-
tile vomiting. There was no history of trauma. There
was tracheal shift to the right and absent breath sounds
in left lung field. Chest X-ray showed shift of trachea
to the right, air fluid level in the left thorax. Ultraso-
nography of the thorax showed bowel loops in left tho-
rax. CT-scan suggested herniation of stomach into left
hemidiaphragm with left hydrothorax. Patient was
subjected to emergency surgery, the defect was wid-
ened, contents were reduced, and stomach was healthy.
The defect was closed. Post-operative period was
uneventful.
Results: Radiography plays a key role in diagnosis
including CT scanning. A patient’s prognosis depends
on the size of the diaphragmatic defect and whether
there is damage to associated organs. Early diagnosis
and urgent management are critical for reducing the
likelihood of gastric necrosis.
Conclusions: Radiography plays a key role in diagnosis
including CT scanning. A patient’s prognosis depends
on the size of the diaphragmatic defect and whether
there is damage to associated organs. Early diagnosis
and urgent management are critical for reducing the
likelihood of gastric necrosis.
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ISOLATED SPLENIC HYDATIDOSIS
Ibrahim Abdelkader Salama1, Mohamed Houseni1
El-Amir Amir1
1National Liver Institute,Menophyia University, Egypt
Introduction: Hydatid disease is still a health problem
in endemic areas. Extrahepatic hydatid cyst is rare, and
primary (isolated) splenic cyst is a rare clinical entity,
constituting 1.5 to 3.5% of all hydatid cysts.
Method: Objective: to determine the incidence and
treatment options of isolated splenic hydatidosis.
Patients & Methods: We reported series of isolated
splenic hydatid cysts admitted at Hepatobiliary tertiary
center, National Liver Institute, Menophyia University,
in a period from March 2005 to January 2012 managed
surgically with open splenectomy (total and partial).
Results: Out of 439 patients of abdominal hydatidosis
18 (4%) had isolated splenic hydatidosis, Aged range
26–67 years, Twelve (66.5%) were male and six (33.5%)
were female. Nine patients (50%) were presented by
splenomagly, four patients (22.2%) were presented by
left hypochondruim mass, two patients (11%) had acute
abdomen and other 3 patients (16.5%) diagnosed inci-
dentally. Fourteen patients (78%) underwent elective
splenectomy, two patients (11%) had urgent abdominal
exploration and open splenectomy and two patients
(11%) had elective partial splenectomy. No mortality,
but complications occurred in 4 patients (22.2%).
Hospital stay was 4–11 days. No recurrence was noted
during follow up period 12–60 months proved clinically
and radiologically.
Conclusions: A high degree of suspicion of hydatid
should be there whenever a splenic cyst is encountered
in clinical practice and treatment options should be tai-
lored for each case.
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